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Effects of the administration of a bolus of 7,2% hypertonic saline solution in horses with 
colic, as a part of medical treatment: a preliminary study. 
Catarina Stilwell  
Abstract 
The present study is a preliminary study that aims to determine the existence of a beneficial 
effect in the administration of a bolus of 7,2% hypertonic saline solution, as a part of medical 
treatment, to horses suffering from gastrointestinal colic and in need of IV fluid therapy.  
Eight horses were enrolled in this study and divided into two groups: LRS group that received a 
2L bolus of lactated Ringer’s solution and HSS group that received a 2L bolus of 7,2% 
hypertonic saline solution. Blood pressures and several blood parameters were collected for all 
horses before (T0), immediately after (T1) and 90 minutes after (T2) the administration of the 
fluid bolus. Between T1 and T2 all horses received approximately 10 litters of plasma - Lyte A, 
intravenously. No horse received oral fluids for the duration of this study. 
Blood pressures increased at T1 for the HSS group while all blood parameters decreased, 
except for blood urea nitrogen which remained similar to T0. At T2, the blood pressures for the 
HSS group were lower than at T1 but higher than at T0.  Lactate concentrations decreased 
continuously for the HSS group and increased at T1 for the LRS group.  
Despite the small sample of horses used in this study, there seems to exist strong evidence of 
the beneficial effects of the administration of hypertonic saline solution to horses with medical 
colics. 
 







Efeitos da administração de um bólus de soro salino hipertónico a 7,2% em cavalos com 
colica, como parte do tratamento médico: um estudo preliminar. 
Catarina Stilwell 
Resumo 
O presente estudo tem como objectivo determinar a existência de um efeito benéfico na 
administração de um bólus de soro salino hipertónico a 7,2%, como parte do tratamento 
médico, a cavalos com cólica gastrointestinal e com necessidade de receber fluidoterapia IV. 
Foram admitidos oito cavalos neste estudo e divididos em dois grupos: grupo LRS que recebeu 
um bólus de 2L de lactato de Ringer e o grupo HSS que recebeu um bólus de 2L de soro salino 
hipertónico a 7,2%. Pressões sanguíneas e vários parâmetros sanguíneos foram avaliados em 
todos os cavalos antes (T0), imendiatamente depois (T1) e 90 minutos depois (T2) da 
administração do bólus de fluido. Entre T1 e T2 todos os cavalos receberam cerca de 10 litros 
de plasma - Lyte A, intravenosamente. Nenhum cavalo recebeu fluidos orais durante a duração 
deste estudo. 
As pressões sanguíneas aumentaram em T1 no grupo HSS enquanto todos os parâmetros 
sanguíneos diminuíram com execepção da ureia, que permaneceu semelhante a T0. Em T2, as 
pressões sanguíneas para o grupo HSS eram inferiores a T1 mas superiores a T0. As 
concentrações de lactato diminuíram continuamente para o grupo HSS mas aumentaram em T1 
para o grupo LRS. 
Apesar da reduzida amostra usada neste estudo, parecem existir fortes evidências dos efeitos 
beneficos da administração de soro salino hipertónico a cavalos com cólicas médicas. 
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This work was performed during the 6th year of the Integrated Masters in Veterinary Medicine of 
the Faculty of Veterinary Medicine, University of Lisbon, under the supervision of Dr. Benjamin 
Buchanan and Professor Paula Tilley. 
I did my internship at the Brazos Valley Equine Hospital (BVEH) in Navasota, Texas, USA, 
where I spent about 5 months split in two periods. For the first period I lived at the hospital from 
September 28 to December 18 and worked with the senior practitioners during the day and with 
the interns during the night as an intensive training period. For the second time, from April 4 to 
June 14 I did not live at the hospital but spent my days with the practitioners and interns, only 
driving to the hospital at night if one of the cases for my study was coming in as an emergency. 
The BVEH Navasota consists of a fully equipped laboratory, a surgery room with two 
induction/recovery rooms, two appointment rooms with two sets of stocks each and facilities to 
hospitalize more than 50 animals including an ICU unit with four stalls and an isolation unit with 
two stalls. At the time of my internship three board-certified specialists in Surgery, Internal 
Medicine and Emergency/Critical Care, and Reproduction as well as two more practitioners 
worked at the hospital. The hospital’s caseload is quite large and consists mostly of horses and 
ponies (95%) but also donkeys, miniature donkeys, llamas and alpacas. In 2015 the hospital 
attended 13,903 animals split approximately in 40% sports medicine, 20% internal medicine, 
10% dentistry/wellness, 10% reproduction, 5% complimentary medicine, and 5% pre-purchase 
examinations. 
Through my training period I perfected skills like administering 
medication IM, IV and orally, passing nasogastric tubes and 
checking for gastric reflux, placing IV catheters, performing a 
complete physical exam in adults and neonates, flexing limbs 
for lameness exams and evaluating lameness, applying 
bandages, suturing and caring for wounds, among others. I 
also got the chance of learning numerous new skills such as 
performing an upper airway, tracheal and gastric endoscopy, 
doing a bronchoalveolar lavage, flushing guttural pouches, 
performing a temporary tracheostomy on cadavers and 
assisting surgery for permanent tracheostomy (Figure 1), learning how to ultrasound lungs, 
abdomen, umbilicus and limbs, doing nerve and skin blocks and regional limb perfusions, 
placing subpalpebral lavage systems, performing abdominocentesis, measuring central venous 
pressure, assisting surgery and anesthesia and using several laboratory tests and machines. 
Figure 1: Permanent tracheostomy 
performed after a temporary one had 




I had the opportunity of witnessing several surgeries including for colics by intestinal 
strangulation, impaction, 
torsion or obstruction by a 
foreign body (Figure 2), 
various orthopedic cases 
of fractures, arthrodesis, 
joint or tendon sheets 
lavages, correction of 
angular and flexural 
defects and 
osteochondrosis, one case 
of an ethmoid hematoma, one resolution of an esophageal fibrotic scar, one paranasal sinus 
cyst and several sinusitis from rotten teeth roots, many permanent tracheostomies due to 
nasopharyngeal cicatrix syndrome, various lacerations (Figure 3), several castrations, umbilical 
hernia resolutions and two enucleations. I also had the chance to watch Dr. Dennis Brook, from 
the University of Florida, performing three cataract surgeries and one iris abscess removal. 
In the internal medicine, neonatology and emergency/critical care area I saw several interesting 
cases including several infections by Streptococcus equi equi (Strangles), two resolutions of 
large colon right displacement by rolling the horse and trocharising the large colon through the 
abdominal wall, numerous medical resolutions of gastrointestinal colics, several cases of Equine 
Asthma (Figure 4), several adult horses, foals and one zebra 
with diarrhea (Figure 5), two cases of very severe 
suppurative pneumonia that ended up in one of the horses 
dying and the other being euthanized, two cases of dummy 
foals one of which suffered three fractured ribs during labor 
having to be submitted to surgery at 48h of life and surviving 
to recover completely (Figure 6), several Rhodococcus equi 
infections in foals with systemic complications on a miniature 
Figure 2: Calcified rope removed from the 
small colon of a 5yo mare with acute colic, 
very painful and with low response to 
analgesia and sedation. Nail brush for 
scale. 
Figure 3: Two large lacerations. The 
horse on the left had a big 
sequestrum on the dorsal aspect of 
the cannon bone that was later 
removed. 
Figure 4: Horse with Equine Asthma 
using an aerosol mask. 
Figure 5: One year old zebra with 
severe diarrhea receiving IV 
fluids. 
Figure 6: 48h old dummy foal with oxygen line 
and feeding tube after surgery for correction 
of three ribs fractured during labor. 
Figure 7: The first hoof to fall 
from a septic two month old filly. 
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Figure 8: Use of acupuncture to 
manage pain on a 12yo mare 
with laminitis after colic surgery.
foal that ended up dying, one hyper-acute laminitis secondary to septicemia in a two month old 
filly that lost three hooves and had to be euthanized (Figure 7) and one diaphragmatic hernia 
from unknown cause with entrapment of the liver and spleen and splenic rupture on a 20 year 
old horse that was euthanized 24h after being admitted to the hospital.  
I also observed the use of acupuncture to manage pain in several post-operative cases (Figure 
8) and as treatment or therapeutic aid for cases of Equine Asthma, sweeney shoulder, laminitis, 
back and neck pain and navicular syndrome. On the reproduction area, I assisted with semen 
collection, natural breeding and artificial insemination, helped synchronizing oestrus and foaling 

































































































































































































I thought that one surgical case was particularly interesting. A nine year old Arabian mare, seven 
months pregnant, was observed at the farm with acute signs of abdominal colic. The mare had 
had surgery for colic about a year before that and showed to be very painful. As the response to 
analgesia and sedation was weak and brief she was immediately refered to the hospital with 
indication for abdominal surgery. Surgery was conducted normally being that the cause for colic 
was an entrapment of the small intestine through a net in the mesentery, probably originated on 
the previous surgery. A resection and anastomosis was performed and the mare was up in the 
stall shortly after. The in utero foal showed good signs of vitality after surgery but progesterone 
was still administered orally to the mare for the time of recovery. The post-surgery antibiotic 
therapy was done following the hospital’s protocol with penicillin and gentamicin IV as well as 
analgesic and anti-inflammatory therapy with flunixin meglumine IV. For four days following 
surgery the mare kept refluxing large amounts of fluid and feed material. By the fourth day she 
received a one liter bolus of 7,2% hypertonic saline solution IV on the grounds that it would 
decrease the swelling of the anastomosis site, improving motility and reducing the amount of 
reflux produced. On the fifth day the mare stopped producing reflux and was fed a liquid meal 
made with senior equine feed dissolved in water. For the next week the same meal was 
provided every six hours and alfalfa hay was introduced gradually to the mare’s diet. By the end 
of the second week post-op the mare started showing signs of abdominal discomfort and spiked 
Figure 9: First time foaling mare and 
Dr. Modesto assisting the foal to stand 
and nurse.




a fever. On abdominal ultrasound the foal showed no signs of vitality and it was spontaneously 
aborted later that same night. Even though there were no signs of retained placenta or any 
further complications related to the abortion, the mare’s condition kept worsening and she 
started refluxing again having to be taken back to surgery by the end of the third week after 
being admitted to the hospital. Although the anastomosis site showed no signs of complications, 
there were some small intestine adhesions that were considered the cause of colic and the 
surgery went on without complications. For the following weeks the mare recovered well from 
surgery but developed severe laminitis on both front feet. Besides special shoeing and medical 
treatment, acupuncture was also used to manage pain. At the end this mare stayed at the 






Colics are among the most important medical problems in equine medicine and, despite their 
relevance, there is still a lot to be understood about this disease (Cohen, 2002).  
There is a constant search for better ways to improve recovery and survival of horses with colic 
and the use of hypertonic saline solution (HSS) has been a target of this quest. 
It’s been almost a century since the first benefits of hypertonic saline solutions were discovered 
but it wasn’t until after 1960 that this solution’s effects on hypovolemic animals started being 
investigated. The effects of HSS on equine colics only became a focus of investigation in the 
80’s when there was an increase of interest in this solution’s properties.  
Before the benefits of HSS in hypovolemic animals were discovered, intravascular fluid deficits 
had to be corrected by administrating large volumes of isotonic crystalloid fluids. The process of 
administering large volumes of fluids implies a longer resuscitation time and an increased risk of 
fluid overload, besides the fact that, in field situations, it may reveal hard to have access to such 
amounts of fluids. Although there are some situations where the use of hypertonic solutions is 
contraindicated, in hypovolemic animals this type of fluids will cause a considerable expansion 
of plasma volume, alongside with other effects, which will secure organ perfusion and vital 
functions for enough time to allow the necessary volume of replacement fluids to be 
administered.  
Other benefits of hypertonic saline solutions, besides plasma expansion, have been studied and 
include the improvement of cardiac function, venodilation, immunomodulatory and anti-
inflammatory properties and reduction of reperfusion injuries, among others ( Schmall, 1989; 
Reitan, & Moore, 1998; Kien, Kreimeier & Messmer, 2002; Oliveira, Velasco, Soriano, & 
Friedman, 2002; Pantaleon, 2006; Strandvik, 2009; Fielding & Magdesian, 2011; Urbano et al., 
2012 Chimabucuro et al., 2014;). 
Although most of the existent literature about the use of hypertonic solutions in horses with colic 
seems to focus on surgical cases, we believe that medical cases can also benefit from the 




CHAPTER I – Bibliographic Review 
1.1. Equine Colic 
The term colic is used to describe the presence of abdominal pain, being, in reality, a generic 
term for a much more complex setting of problems with a variety of causes (Bentz, 2004a).  
There are nearly 100 recognized causes for colics in horses and although many go by 
undiagnosed, especially the ones treated in the field, there seems to be a certain correlation 
between age, sex and breed and specific types of colic (Cohen, 2002). For example, young 
animals seem to be more prone to intussusceptions while strangulating lipomas are more 
common in older horses. Although there isn’t a consistent relation between colic occurrence and 
gender there are some forms of colic that happen exclusively in one of the genders, such as 
uterine torsions in mares and scrotal herniation in stallions and geldings, and others that seem 
to be more frequent in some sexes despite the lack of epidemiologic studies like colonic torsions 
in mares after parturition (Cohen, 2002). Older horses also appear to be in higher risk of colic 
and of needing surgical treatment but also have better prognosis for survival (Cohen, 2002). The 
Arabian breed has been reported to have increased risk of colic, younger miniature horses have 
a bigger prevalence of fecaliths and impactions of the small colon, and Standardbreds have a 
higher risk of scrotal herniation (Cohen, 2002). 
Some of the most common causes for equine colic not related to the GI tract, also known as 
“false colics”, include the reproductive tract: uterine torsion, dystocia, ovulation, retained 
placenta, uterine hematoma or perforation and orchitis; the urinary tract: ruptured bladder, 
cystitis, pyelonephritis and calculi of different etiology; hepatic or splenic causes: acute hepatitis 
and splenic abscess; peritonitis and neoplasia (Bentz, 2004b; Mair, 2002b) .  
It is important to remember that, when looking for the cause for a colic, one must not forget 
about other conditions that, even though are not related with abdominal pain, may mimic some 
clinical signs and lead to confusion about the diagnose. These disorders can be related, among 
other causes, with the musculoskeletal system: laminitis, rhabdomyolysis; the cardiorespiratory 
system: pneumonia, pleuritis; the cardiovascular system: acute hemorrhage, myocardial 
infarction or pericarditis; the nervous system: tetanus, botulism, hypocalcemic tetany or equine 





Predisposing factors, besides the signalment referred above, for the occurrence of 
gastrointestinal colics are described on Table 1. 
Table 1: History findings, predisposing factors and potential mechanisms for the occurrence of colics in 
horses. Adapted from Blikslager and Jones (2010) and Cohen (2002). 
History findings, predisposing factors and potential mechanisms for the occurrence of  
gastrointestinal colics. 
History finding Predisposing factor Potencial mechanisms 
Feeding 
Recent change in feeding  
Large infrequent meals 
Alteration on fluid flux or fermentation in the 
large colon 
Hay with high fiber content Obstruction of ileum by fine, fibrous hay 
Feeding round bales Poor quality hay 
Feeding off the ground Ingestion of sand from soil 
Bolting feed 
Large boluses of feed entering esophagus and 
stomach 
Enviroment 
Excessive time in stall 
Insufficient intake of roughage 
Insufficient exercise 
Insufficient access to water Dehydration 
 High density housing Stress, bolting feed 
Exercise Exaustion 
Dehydration 
Reduced GI motility 
Preventive care 
Insufficient dental care Poor mastigation of feed 
Insufficient deworming  Large parasite burden 
Medication 
Excessive  NSAIDs 
administration  
Mucosal damage, particularly in the stomach 
and colon 
Medical history Colic surgery 
Adhesions 
Anastomotic obstruction 
Farm management Bad caretaker 
Lack of appropriate care of horses with 
previous history of colic 
Weather 
Warm months  Dehydration from sweating 





Given the presented study was based solely on adult horses suffering from hypovolemia due to 
gastrointestinal colic, I will focus on a deeper review about gastrointestinal colics in horses and 
their repercussions in the body’s fluid balance. 
1.1.1. Hypovolemia and dehydration 
One must be aware of the differences between hypovolemia and dehydration since both 
conditions require distinct approaches (Corley, 2008a). Even though both conditions may be 
present in the same horse, hypovolemia is the term used to describe the reduction of circulating 
blood volume whereas dehydration is the loss of interstitial fluid without decline of volemia 
(Corley, 2008a).  
Hypovolemia can be considered absolute, where there is actual loss of intravascular volume due 
to diarrhea, hemorrhage or increased capillary permeability, among others; or relative, when the 
plasma volume remains the same but the intravenous compartment expands like in situations of 
systemic venodilation following SIRS or the administration of vasodilatory drugs (Magdesian, 
2015b). Hypovolemia compromises organ perfusion and might result in permanent organ 
damage and death if not addressed correctly and in time (Magdesian, 2015b). 
Hypovolemic horses that have lost 8 -10L of plasma volume, which represents about one 
quarter of total blood volume for a 500Kg horse, show clinical signs like slow jugular fill, 
tachycardia and tachypnoea,  reduced urine output, cold extremities and weak pulse (Corley, 
2008a; Hassel, 2015; Magdesian, 2015b). The main therapeutic goal for hypovolemia is to 
quickly replace blood volume, increase blood pressure and cardiac output and secure organ 
perfusion, which can be achieved by administering large volumes of isotonic crystalloid 
solutions, smaller volumes of hypertonic solutions or an association of both (Corley, 2008a; 
Magdesian, 2015b).  
Horses that have fluid losses of more than 5% of their body weight may show dehydration signs 
such as tacky or dry mucous membranes, decreased skin turgor, sunken eyes and tachycardia 
(Corley, 2008a; Hassel, 2015; Magdesian, 2015a). Due to the body’s physiologic mechanisms to 
maintain an appropriate circulating volume by drawing extravascular fluid into the vessels, 
hypovolemia due to dehydration only happens in severely dehydrated animals (Corley, 2008a). 
Fluid therapy in dehydrated horses is aimed at replacing interstitial fluid losses over a period of 
12 to 24 hours, which should be achieved through the administration of isotonic crystalloid 
solutions (Corley, 2008a; Magdesian, 2015a).  
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1.1.2. Hemodynamic changes in colic 
Total body water content of an adult horse is estimated to be about 60% to 70% of the body 
weight and is divided into three major spaces or compartments: intracellular (ICF), intravascular 
and interstitial, the last two are commonly referred as extracellular fluid compartment (ECF) 
(Fielding, 2015a; Seahorn & Seahorn, 2003).  
Water present in the adult horse’s gastrointestinal tract is thought to be approximately 6 to 10% 
of total body weight (Seahorn & Seahorn, 2003). The degree of fluid deficit of a horse with colic 
may vary from mild dehydration to hypovolemic shock (Seahorn & Seahorn, 2003). 
Factors such as type of colic, duration of colic and ongoing losses should be taken into account 
when assessing the circulatory status of a horse with colic (Divers, 2002; Hassel, 2015). Fluid 
losses through sweating, increased gastric and intestinal secretions, decreased water intake and 
decreased intestinal absorption all contribute more or less for the onset and aggravation of fluid 
derangements (Divers, 2002; Hassel, 2015). 
Initial losses will cause a reduction in extracellular fluid but as fluid depletion progresses, 
intracellular fluid may be lost as well (Divers, 2002; Hassel, 2015). Most horses suffering from 
colic for more than a day will show clinical signs of dehydration (Hassel, 2015). However, acute 
processes, such as strangulating lesions and proximal obstructions, will likely be accompanied 
mainly by hypovolemia secondary to a number of events such as endotoxemia, hypersecretory 
states, and increases in endothelial permeability (Hassel, 2015). 
Loss of integrity of the gastrointestinal barrier will promote the passage of endotoxin producing 
Gram negative bacteria leading to endotoxemia and, more severely, to endotoxic shock 
(Pantaleon, 2005). Endotoxemia may originate a capillary leak syndrome which is described as 
the loss of fluid, with or without protein, into the interstitium due to increased endothelial 
permeability (Pantaleon, 2005). Endotoxemia also leads to arterial and venous dilation and, 
eventually, decreased cardiac output, which aggravate even further the patient’s hypovolemic 
status (Pantaleon, 2005). 
Situations of intestinal obstruction can also result in increased capillary filtration or leakage 
(Seahorn & Seahorn, 2003; Hassel, 2015). Intestinal obstructions result in distension of the 
proximal portion of intestine due to accumulation of digesta, fluid, gas and secretions. The 
increased intraluminal pressure compresses the veins in the intestinal wall and increases the 
capillary filtration rate into the interstitium. If the rate of fluid secretion is greater than the one 
removed by lymph flow, then edema and accumulation of fluid within the intestinal and/or gastric 
lumen increase (Freeman, 2002). Distension of the intestinal lumen can be such that causes 
necrosis of the surrounding tissues  (Blikslager & Jones, 2010b). 
Plasma protein losses, through diarrhea, into the intestinal lumen, in abdominal effusion, and 
due to increased permeability of the endothelium contribute for the loss of oncotic pressure 
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within the vessels and to the onset or worsening of intravascular fluid loss and tissue edema (T. 
Divers, 2002; Seahorn & Seahorn, 2003). 
 
1.1.3. Fluid therapy according to type of colic 
Even though there are innumerous causes of colic in horses, it is possible to divide the most 
common into non-strangulating mechanical obstructions, strangulating obstructions and 
functional obstructions (Hassel, 2015). 
1.1.3.1. Non-strangulating mechanical obstructions 
Non-strangulating obstructions can be partial or complete and are caused by an intraluminal 
obstacle to the progression of digesta without, however, causing obstruction of the blood flow 
(Bentz, 2004b; Blikslager & Jones, 2010b). Nonetheless, non-strangulating obstructions may 
result in vascular obstruction as explained on chapter 1.1.1. Some of the most common non-
strangulating mechanical obstructions are originated by feed, sand or ascarids’ impactions, 
colonic displacements, foreign body obstructions, sand impactions, enteroliths,	enlargement or 
thickening of the intestinal wall, masses, and intestinal scarring (Bentz, 2004b; Blikslager & 
Jones, 2010b; Hassel, 2015).  
Horses with non-strangulating obstructions normally show signs of moderate dehydration but not 
hypovolemia, therefore, fluid therapy for these cases aims mostly at restoring hydration and 
electrolytes balance using mostly isotonic crystalloid solutions (Hassel, 2015). In situations of 
impaction, fluid therapy may also have the goal of hydrating and dissolving the impaction, even if 
the horse’s hemodynamic status is normal (Blikslager & Jones, 2010b; Hassel, 2015).  
Colonic impactions have traditionally been treated by administering large volumes of IV fluids to 
achieve systemic overhydration, associated to oral administration of a laxative like mineral oil, 
sodium sulfate or magnesium sulfate (Bentz, 2004b; Hassel, 2015; Lopes, White, Donaldson, 
Crisman, & Ward, 2004), however, the amount of IV fluids administered in these situations 
involve some risks and haven’t proved to be more effective than the oral administration of similar 
volumes (Hassel, 2015; Lopes, Walker, White, & Ward, 2002). Aggressive IV fluid therapy is 
justifiable in horses that do not tolerate enteral fluids, either due to the existence of gastric reflux 
previous to oral administration of fluids or caused by it, and in severe cases where enteral fluids 
alone are not enough (Hassel, 2015; Lopes et al., 2004). 
Some colonic displacements can also be managed through IV fluid therapy (Hassel, 2015). 
1.1.3.2. Strangulating obstructions 
A strangulating obstruction results from the complete or partial obstruction of the intestinal lumen 
and corresponding blood supply and are commonly caused by intestinal volvulus, strangulating 
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lipomas, intussusceptions, inguinal and diaphragmatic hernias and entrapments in the epiploic 
foramen, gastrosplenic ligament or mesenteric rents (Bentz, 2004b; Blikslager & Jones, 2010a; 
Hassel, 2015). 
 Strangulating obstructions can be classified as hemorrhagic or ischemic. Hemorrhagic 
strangulating lesions happen when the intestine is twisted or compressed only to the point where 
veins are occluded but arteries are not, due to their more rigid wall. The affected intestine is dark 
and enlarged as blood flow keeps being pumped into the vessels but not out of them (Blikslager 
& Jones, 2010a). Ischemic strangulating lesions result from a tightly twisted intestine capable of 
occluding both veins and arteries and is rarer than the previous. The affected bowel is pale and 
of normal or thinner thickness (Blikslager & Jones, 2010a).  
Both types of strangulating obstructions cause quick deterioration of the patient’s condition and 
should be handled as surgical emergencies (Hassel, 2015). 
Horses suffering from a strangulating obstruction are almost always in need for IV fluid therapy 
as hypovolemia, endotoxemia and systemic inflammatory response syndrome (SIRS) are 
frequently present (Blikslager & Jones, 2010a; Hassel, 2015). The first approach to these cases 
should be to restore volemia and secure organ perfusion. The administration of hypertonic saline 
solution associated or not to a colloid solution is often advised to quickly promote plasma 
expansion and improve microcirculation, organ perfusion and cardiac function besides other 
benefits that will be further explained on chapter 1.4. (Blikslager & Jones, 2010a; Hassel, 2015). 
To assure the maintenance of these effects one must provide the appropriate amount of isotonic 
polyionic solutions following the administration of the hypertonic solution (Hassel, 2015). 
1.1.3.3 Functional obstructions 
Functional obstructions are the consequence of an inflammatory condition known as duodenitis-
proximal jejunitis, proximal enteritis or anterior enteritis, characterized by inflammation of the 
proximal small intestine and resulting in ileus (Bentz, 2004b; Hassel, 2015). Although the 
etiology is not yet fully understood, it is believed that Clostridium spp., Salmonella spp. and 
some mycotoxins	  play an important role in the development of anterior enteritis (McConnico, 
2010; Hassel, 2015). The inflammatory process and reduction in motility lead to a large 
accumulation of fluid in the small intestine and stomach (Bentz, 2004b; McConnico, 2010; 
Hassel, 2015). As fluid accumulates, the stomach and small intestine become distended and 
painful and the horse becomes dehydrated and hypovolemic (Bentz, 2004b; Hassel, 2015). 
Many cases of anterior enteritis are accompanied by SIRS, which contributes even further for 
the depletion of the horse’s hemodynamic status (Hassel, 2015). Horses with functional 
obstructions produce large amounts of gastric reflux that can sometimes be spontaneous 
(Hassel, 2015; McConnico, 2010). These horses almost always have prerenal azotemia and 
12	
	
electrolyte derangements (Johnston & Morris, 1987; Bentz, 2004b; McConnico, 2010; Hassel, 
2015).  
Aggressive IV fluid therapy should be started as quickly as possible. Hypertonic saline solution 
or colloids can prove useful in restoring plasma and should be followed by large volumes of 
isotonic polyionic crystalloid solution (McConnico, 2010). When planning fluid therapy for horses 
with functional obstructions it’s important to have in account that these horses are in great need 
for fluid replacement and of expansion of the plasma volume, and that the ongoing losses from 
gastric reflux are very significant. However, because of the high secretion of electrolytes and 
protein into the intestinal lumen, horses with anterior enteritis tend to have low plasma oncotic 
pressure which means that, with fluid resuscitation there is also an increased risk of edema 
formation and further fluid secretion into the intestinal lumen. Therefore, the use of synthetic or 
natural colloids should be considered for horses with low plasma protein concentrations (Hassel, 
2015; McConnico, 2010). 
1.2. Fluid therapy 
1.2.1. 0,9% Sodium chloride and Isotonic polyionic solutions  
Although 0,9% Sodium chloride is usually known as isotonic or normal saline, it is actually 
slightly hypertonic compared to horse plasma (Magdesian, 2015a). Its composition is mildly 
hypernatremic and significantly hyperchloremic compared to horse plasma being, therefore, 
recommended for the treatment of hyponatremic and hypochloremic patients. Also, because of 
its high concentration in chloride and absence of a buffer component, this solution’s acidifying 
properties can lead to a hyperchloremic metabolic acidosis (Cazzolli & Prittie, 2015) but, at the 
same time, make it a suitable treatment for hyperkalemic patients such as postpartum mares 
with a ruptured bladder (Cook & Bain, 2003). Animals being treated with 0,9% sodium chloride 
should be closely monitored for electrolyte disturbances since this is a solution lacking all other 
electrolytes in its composition. 
Isotonic polyionic solutions (IPS) are considered balanced solutions and are more physiologic 
than isotonic saline solution since they have an electrolyte composition similar to plasma as well 
as a buffer component, making them a better fit for most fluid resuscitation cases (Cazzolli & 
Prittie, 2015). This type of fluids can be classified as maintenance or replacement solutions 
according to their composition (Cook & Bain, 2003; Magdesian, 2015a). 
Maintenance IPS have a higher concentration of potassium and a lower concentration of sodium 
which allows for a long-term administration without the risk of hypernatremia or hypokalemia 
occurring (Cook & Bain, 2003). Maintenance fluid rate is considered to be 2,5 mL/kg/h  or 60 
mL/kg/d for adult horses (Cook & Bain, 2003; Magdesian, 2015a).  
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Replacement IPS have a relatively low potassium concentration (Table 2) making them similar 
to the extracellular fluid and ideal for situations where fluid resuscitation is required. The low 
potassium concentration of these fluids prevents the risk of iatrogenic hyperkalemia due to the 
high rate of which these fluids need to be administered (Cook & Bain, 2003; Magdesian, 2015b).  
 
Table 2: Composition of different types of crystalloid solutions used in equine medicine compared to horse 
plasma. Adapted from Magdesian (2015b) and Cook and Bain (2003). 
 
Normosol-R, Plasma Lyte-148 and Plasma Lyte- A are the most common replacement solutions 
for horses. These fluids differ only in their pH, making Plasma Lyte-A the most physiological for 
horses  (Magdesian, 2015b). These fluids contain acetate and gluconate as buffers and 
therefore are advised in patients with liver dysfunctions since acetate is metabolized by muscle, 
liver and kidney cells and gluconate is metabolized by the big majority of body cells (Cook & 
Bain, 2003; Magdesian, 2015b). 
Because lactate is metabolized by the liver and  kidney, the presence of hepatic abnormalities 
may be a contraindication for the administration of Lactated Ringer’s Solution or Hartman’s 













pH mOsmol/L Buffer 
Horse 
Plasma 




154 154 0 0 0 5,0 308 None 
7,2%  
HSS 
1232 1232 0 0 0 4.0 2464 None 
LRS 130 109 4 3 0 6,5 272 Lactate 
Normosol 
– R 










140 98 5 0 3 5.5 295 
Acetate 
Gluconate 
LRS: Lactated Ringer’s solution     
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1.2.2. Risks of large volume resuscitation with crystalloids 
Crystalloid fluids bear negligible oncotic pressure and they’re main electrolyte is sodium. Sodium 
is also the main electrolyte present in the extracellular space being that about 75% of it is 
located in the interstitium (Cook & Bain, 2003; Cazzolli & Prittie, 2015). This fact explains why 
about 60 to 80% of the infused volume disseminates into the interstitial space within 30-60 
minutes, making it so that considerably large amounts of these fluids must be administered 
before normovolemia is achieved (Cook & Bain, 2003; Magdesian, 2003; Cazzolli & Prittie, 
2015). 
The administration of large volumes of isotonic crystalloids may be necessary to revert 
hypovolemic shock and restore appropriate organ perfusion making fluid overload a common 
complication in human and small animal medicine (Cazzolli & Prittie, 2015). Fluid infusion should 
be closely monitored as a cascade of events following fluid overload will worsen the patient’s 
prognosis (Cazzolli & Prittie, 2015). Although a significant amount of the administered fluids is 
believed to be excreted in urine, a high infusion rate may still result in interstitial edema 
formation (Cook & Bain, 2003; Fielding, 2015). As fluid load increases, the extracellular space 
expands, compressing and damaging the structure of the endothelial surface layer leading to 
capillary leak and tissue edema formation (Cazzolli & Prittie, 2015; Fielding, 2015). These types 
of fluids will also increase the production of inflammatory cytokines and endothelial cell 
activation due to their proinflammatory properties, aggravating the formation of tissue edema 
and hypoxia (Cazzolli & Prittie, 2015; Fielding, 2015). Other complications resulting from 
aggressive fluid resuscitation include dilutional coagulopathy, compartment syndromes, cellular 
swelling, reduced cell activity and impaired tissue healing (Cazzolli & Prittie, 2015).  
In equine medicine clinical signs of fluid overload are rare in adult horses with normal renal and 
cardiac function. However, horses with renal failure (Corley, 2008a), increased capillary 
permeability and reduced oncotic pressure due to SIRS or horses with acute respiratory distress 
syndrome (ADRS) are more prone to getting overhydrated and developing life threatening 
pulmonary edema (Fielding, 2015). In these cases fluids should be administered as conservative 
boluses instead of continuously infused (Corley, 2008; Fielding, 2015). 
Although foals barely tolerate dehydration, fluid overload in equine neonates can represent an 
equally threatening condition, easily leading to lung and cerebral edema and seriously 
compromising the cardiorespiratory, renal and hepatic systems. A close monitoring of these 
patients is of the utmost importance and several authors claim that, as long as renal function is 
secured, a small restriction of the infused volume is preferable to the risk of overhydrating and 
that administering fluid as boluses should only be allowed for emergency resuscitation (Corley, 
2008a; Knottenbelt, Holdstock, & Madigan, 2004; Palmer, 2006; Wilkins, 2010).  
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Volume overload can be avoided or early detected by monitoring parameters such as central 
venous pressure (CVP), arterial pressure, jugular fill (Corley & Stephen, 2008; Hardy, 2010; 
Palmer, 2006), urine output, particularly in the neonate, urinary specific gravity, blood hematocrit 
and total solids (Knottenbelt et al., 2004; Palmer, 2006; Hardy, 2010). The presence of white-
pink foamy nasal discharge accompanied by dyspnea is an indication of pulmonary edema, the 
most important sign of fluid overload, and should be assessed with furosemide given as an IV 
bolus and reduction or interruption of fluid administration. Some cases may require intranasal 
oxygen supplementation (Corley, 2008a). Changes in mental status, especially in the neonate, 
can also work as an indicator of the hydration status (Palmer, 2006). 
1.2.3. Hypertonic Saline Solutions  
A hypertonic solution is any solution with a concentration higher than its respective isotonic form. 
This can be achieved by using high concentrations of sodium, glucose, mannitol and other 
components (Kreimeier & Messmer, 2002). 
Hypertonic saline solutions (HSS) have higher concentrations of sodium and chloride than 
isotonic saline solutions, meaning, than 0,9%. HSS are normally sold in variations of 3%, 5% or 
7%, being that the ones most commonly used in equine practice are 7,2% to 7,5% (Duval, 1995; 
Magdesian, 2015b). HSS more concentrated than these are usually primary solutions to be used 
in association with other types of fluids such as dextran or hetastarch (Duval, 1995). Even 
though HSS are contraindicated in some situations and may involve some risks, they are 
generally safe and effective as well as much more affordable than colloids. 
It’s been 90 years since the use of hypertonic saline solutions was first described by Silbert et al 
(1926) as treatment for Buerger’s disease or thromboangiitis obliterans (Duval, 1995). But it 
wasn’t until 1963 that Brook’s et al described the use of a hypertonic saline solution in dogs 
suffering from hemorrhagic shock as a way to prevent tissue damage and improve recovery. In 
1980, Velasco et al increased the popularity of HSS by showing that the administration of a 4 
mL/Kg bolus of 7,5% HSS to severely hemorrhagic dogs restored the blood pressure and acid-
base equilibrium quickly. From the 80’s forward, the number of studies concerning the efficacy of 
different hypertonic solutions, concentrations, doses, infusion rates and administration routes 
increased greatly both in human and in veterinary medicine.  
In 1984, Nakayama et al used the concept of small-volume resuscitation (SVR) to describe the 
fast administration of a small dose of hypertonic saline solution (approx. 4 ml/kg of 2,400 
mosm/L HSS) to manage hypovolemic shock as an alternative to large volumes of isotonic 
crystalloids (Kreimeier & Messmer, 2002).  
Several mechanisms of action for the effects of hypertonic saline solutions have been 
suggested, studied and proven or contested. The most commonly accepted and better explained 
is the expansion of plasma volume. Several authors have tried to define the real increase in 
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plasma volume that is due to the administration of HSS, being that an increase two to five times 
the administered volume of HSS seems to be the most consensual values (Kien, Reitan, & 
Moore, 1998; Cook & Bain, 2003; Magdesian, 2015b). Fielding and Magdesian (2011) 
concluded that endurance horses requiring IV fluid therapy and treated with a bolus of 7,2% 
hypertonic saline solution had an increase in plasma volume of 29,1 ± 4% while horses treated 
with 0,9% isotonic saline solution had significantly smaller increase of 12 ± 14,6%, which roughly 
corresponds to the amount of infused fluids.  
The first explanation for this expansion, to which most authors seem to agree, is a simple rise in 
the plasma’s osmotic pressure that will cause fluid from the interstitial and/or intracellular spaces 
to be drawn to the intravascular compartment (Duval, 1995; Kien et al., 1998; Fielding & 
Magdesian, 2011). Since 96% of plasma osmolality is determined by electrolytes like sodium, 
chloride, bicarbonate, potassium, calcium, magnesium and phosphate, it’s clear how hypertonic 
NaCl solutions are capable of such increases is plasma osmolality (Kreimeier & Messmer, 
2002). 
A study where hypertonic saline solution was administered to anesthetized rats reported not only 
an increase in plasma volume of four to five times the infused volume of HSS but also a 
reduction of 10% of the intracellular fluid volume of muscle and liver cells (Kien et al., 1998). 
Kien et al (1998) suggest skeletal muscle as the major mobilized fluid source for plasma 
expansion after HSS administration and Fielding and Magdesian (2011) state that the initial shift 
of fluid is from the interstitial space and only later from the intracellular space. Garrido et al 
(2006) consider the intracellular fluid drawn from erythrocytes and endothelial cells to be the 
main responsible for the immediate increase in plasma volume. Constable (2003) also includes 
water present in the gastrointestinal tract as a fluid source for plasma expansion. 
Fettman (1985) references two authors who concluded that, following a physiological response 
to hemorrhagic shock that creates hyperosmolar plasma conditions, the skin and skeletal 
muscle represented the main sources of replacement fluid for the intravascular space. In fact, in 
situations of hypovolemia there is a physiological neurohumoral response that leads to changes 
in peripheral capillary resistance and increases in glycaemia and plasma osmolality. This 
mechanism promotes a fluid shift from the intracellular and interstitial compartments to the 
intravascular space and, at the same time, reduces the intravascular space relatively to blood 
volume (Fettman, 1985; Schmall, 1989). However, this physiologic response is not enough to 
endure a severe hypovolemic state (Schmall, 1989), so hypertonic solutions are considered to 




Another possible explanation is that there is a considerable thirst response triggered by the 
increase in plasma’s sodium concentration meaning that, in cases where the patient is allowed 
to drink, the water intake will contribute for the plasma expansion (Fielding & Magdesian, 2011).  
Hypertonic saline solutions also appear to reduce swelling of erythrocytes (Oliveira, Velasco, 
Soriano, & Friedman, 2002; Magdesian, 2015b) and capillary endothelial cells, often seen during 
hypovolemic and hemorrhagic shock and systemic inflammatory response syndrome ( Kien et 
al., 1998; Oliveira et al., 2002; Corley, 2008a). Reducing erythrocyte swelling associated to the 
plasma expansion will reduce blood viscosity and improve microhemodynamics (Pantaleon, 
2005). Endothelial swelling causes the capillary lumen to reduce, increasing capillary resistance 
and affecting the involved microcirculation, ultimately leading to tissue ischemia. Endothelial 
swelling also restricts the passage of large white blood cells across the vessel’s walls (Kien et 
al., 1998). A study where rabbits were subjected to hemorrhagic shock observed that, within one 
minute after resuscitation with HSS, the blood volume was similar to values previous to 
hemorrhage and that endothelial swelling had reduced by 20% (Kien et al., 1998).  
Adding to the plasma expansion effects, hypertonic saline solutions also carry vasodilator 
properties, mainly on peripheral vasculature. This effect is considered to be the cause for some 
cases of short-lasting hypotension immediately after infusion (Kien et al., 1998; Kreimeier & 
Messmer, 2002; Oliveira et al., 2002). HSS infusion causes the release of vasodilating 
substances such as prostacyclin and increases the 6-keto-prostaglandin F1α : thromboxane B2 
ratio (Oliveira et al., 2002).  Prostacycline is a vasodilator and inhibitor of platelet adhesion and 
aggregation, released by endothelial cells ( Frandson, Wike, & Fails, 2009). 6-keto-prostaglandin 
F1α and thromboxane B2 are stable hydrolysis products of prostacyclin and thromboxane A2, 
respectively. As said before, prostacyclin is a vasodilator and inhibitor of platelet aggregation 
while thromboxane A2 is a vasoconstrictor and an inducer of platelet aggregation, therefore an 
increase in their ration will favor the prostacyclin’s effects (Saldeen & Saldeen, 1983). 
Kien et al (1998) reported a severe decrease in mean arterial pressure 45 seconds after the 
beginning of the administration of hypertonic saline solution at a rate of 2 mL/Kg/min and 3 
mL/Kg/min but not with rates of and under 1 mL/Kg/min. At five minutes post-infusion the mean 
arterial pressure had risen to values similar to baseline for all groups (0,5, 1, 2 and 3 
mL/Kg/min), suggesting that the initial hypotension was due to peripheral vasodilation leading to 
a reduction in peripheral resistance with distribution of the total plasma volume. The authors do 
not state the solution’s concentration or the species of the animals used. Kien et al (1998) also 
showed that the hypotensive effect of HSS in dogs treated with endothelium-derive relaxing 
factor was significantly smaller when compared to dogs treated with autonomic nervous system 
blocking drugs and to not treated dogs, indicating the involvement of mechanisms directly 
related to the endothelium. In a study using a model for hemorrhagic shock in foals, the 
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administration of 32 mL/Kg isotonic saline solution or 4mL/Kg of 7% NaCl in 6% Dextran 70 
produced the same significant increases in mean arterial pressure and cardiac output but the 
reduction in total peripheral resistance was not observed with the administration of 0,9% NaCl 
(Schmall, 1989). The vasodilator properties of HSS have also been proven to exist in salt-free 
hypertonic solutions suggesting this effect may be due to the hyperosmolar effect rather than to 
the presence of a salt (Kien et al., 1998). 
Most of the existing literature agrees that hypertonic saline solutions increase cardiac 
contractility, cardiac output, stroke volume, and improve arterial blood pressures (Schmall, 1989; 
Schmall, Muir, & Robertson, 1990; Pantaleon, 2005; Taylor & Clark, 2007; Robertson, 2010; 
Theobaldo, Barbeiro, Barbeiro, Petroni, & Soriano, 2012; Magdesian, 2015b). Some authors 
discuss if the increase in cardiac contractility caused by HSS administration should be 
considered a direct inotropic effect (Kien et al., 1998; Magdesian, 2015b) as the hyperosmolality 
of the extracellular compartment and subsequent reduction in intracellular water may promote 
the release of calcium ions from the sarcoplasmic reticulum and t-tubules, resulting in higher 
concentrations of intracellular calcium and favoring the cardiac muscle fibers contractility (Kien 
et al., 1998; Pantaleon, 2005). On the other hand, Constable (2003) considers HSS to actually 
have a negative inotropic effect caused by the exchange of extracellular sodium for intracellular 
calcium promoted by the high extracellular sodium concentration, resulting, therefore, in lower 
intramyocyte calcium availability. This contradiction can be explained by some findings reporting 
that moderate degrees of hyperosmolarity will increase cardiac contractile forces whereas the 
opposite happens under severe hyperosmolarity conditions (Oliveira et al., 2002). Some authors 
seem to agree that HSS will have a vasodilator effect on the coronary arteries, improving blood 
supply to the myocardium (Fettman, 1985; Kien et al., 1998) while others consider the 
improvements in cardiac performance to be independent of the increased coronary blood flow 
(Oliveira et al., 2002).  
There is still some discussion about the role of lung innervation on the action mechanisms of 
hypertonic saline solutions. It has been suggested that the high concentration of sodium 
stimulates pulmonary receptors, sending an impulse to the brain through the vagal nerve and 
resulting in a shift of blood flow from the skin and muscle to the vital organs. This was called the 
pulmonary arc reflex (Duval, 1995). Initial studies showed that HSS infusions to the aorta or 
pulmonary vein of hemorrhagic dogs, meaning post-pulmonary circulation, did not produce the 
same resuscitation effects as the intravenous or pre-pulmonary infusions (Schmall, 1989; 
Oliveira et al., 2002). On the other hand, a study conducted with sheep showed no differences in 
the results obtained with peripheral or central administration of HSS (Oliveira et al., 2002). In the 
same way some studies showed the need for the innervation to the lung to be intact for HSS to 
produce a systemic result (Schmall, 1989). However, other authors showed that similar effects of 
19	
	
resuscitation with hypertonic saline are obtained in hypovolemic and hemorrhagic dogs with 
innervated and denervated lungs (Duval, 1995; Oliveira et al., 2002). The vagal nerve is known 
to have an important function on the restoration of hemodynamics in hypovolemia situations and 
several authors showed that animals with vagal blockade and vagotomy produced a reduced 
response or even no response to the administrations of HSS ( Fettman, 1985; Schmall, 1989; 
Duval, 1995; Oliveira et al., 2002;). The number of contradicting literature leaves several 
unanswered questions and creates doubt around the real involvement of this reflex on 
hypertonic saline solution therapy.   
Hypertonic saline solutions have also been showed to have immunomodulatory and anti-
inflammatory effects (Theobaldo et al., 2012; Chimabucuro et al., 2014; Magdesian, 2015b). 
Chimabucuro et al. (2014) studied the effects of 7,5% HSS (4 mL/Kg) and 0,9% normal saline 
(32 mL/Kg) in gut perfusion after ischemia by occluding the superior mesenteric artery (SMA) in 
rats and concluded that the immunologic effects of the administration of a small dose of HSS are 
similar to the ones obtained with a large dose of normal saline without the increased risk of 
edema production. The animals used were distributed in four groups: subjected to SMA 
occlusion treated with HSS, subjected to SMA occlusion treated with normal saline, subjected to 
SMA occlusion but not treated and animals not subjected to SMA occlusion and not treated with 
any type of fluid. Inflammatory and oxidative stress markers were collected for a six hour times 
after gut reperfusion. It is important to notice that the animals not subjected to SMA occlusion 
were still exposed to general anesthesia, abdominal wall incision, gut manipulation and SMA 
handling, having, therefore, relatively increased levels of inflammatory and oxidative stress 
markers. The authors noticed that both groups receiving crystalloids had significant decreases in 
oxidative stress markers and an improved inflammatory response when compared to the not 
treated group. Furthermore, the hypertonic saline solution group had higher plasma levels of 
interleukin 6 and 10, which are pro-inflammatory and anti-inflammatory respectively, but the 
levels of these interleukins in these animal’s tissues were very similar to the group that was not 
subjected to gut ischemia. Even though the levels of pro-inflammatory cytokines are not 
completely annulled by HSS, authors agree that the production of IL-6 will regulate the synthesis 
of IL-10 and an adequate ratio between anti and pro-inflammatory cytokines is crucial for a 
positive outcome (Pantaleon, 2005; Chimabucuro et al., 2014). Several other studies have 
shown the increases in anti-inflammatory cytokines caused by hypertonic saline solution ( 
Pantaleon, 2005; Theobaldo et al., 2012; Magdesian, 2015b).  
The mechanisms for neutrophil activation, migration and infiltration are well known to play a 
major role in the inflammatory response to sepsis or ischemia and have been associated with 
damage to the endothelium, lung, intestines and other tissues, capillary leakage and tissue 
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edema, aggravating even further the tissue hypoxia (Garrido, Cruz, Poli de Figueiredo, & Rocha 
e Silva, 2006; Kreimeier & Messmer, 2002; Pantaleon, 2005; Magdesian, 2015b).   
Neutrophil infiltration was reduced on the HSS and normal saline treatment groups to levels 
similar to the group free of gut ischemia in the study by Chimabucuru et al. (2014). The 
administration of hypertonic saline solution in experimental hemorrhagic shock showed to 
reduce neutrophil activation resulting in reduced lung injury (Corley, 2008a). Elevated levels of 
sodium reduce the neutrophil exaggerated response (Pantaleon, 2005). Moreover HSS reduces 
neutrophil accumulation in the lung, neutrophil - endothelial adhesion and neutrophil 
degranulation decreasing end organ injury (Pantaleon, 2005).  
Other benefits of hypertonic saline solutions may include the indirect release of vasopressin and 
activation of aquaporin channels (Fielding & Magdesian, 2011). Vasopressin is released in both 
plasma hyperosmolality and hypovolemia situations being that the stimulation of volume 
receptors predominates over the osmoreceptors. In this way hypertonic solutions will not inhibit 
this hormone’s secretion through their hyperosmolarity (Fettman, 1985). In hypovolemic animals, 
the increases in vasopressin will prevent water diuresis in order to maintain an adequate plasma 
volume while the activated aquaporin channels will facilitate the water to flow out of the cell 
(Magdesian, 2015b).  
There are many conditions where the use of HSS may be indicated, either alone or combined 
with colloid agents. Severe burns, traumatic brain injury, lung injury, before general anesthesia 
and as resuscitation during circulatory and endotoxic shock are some of the most common 
situations that justify the use of this type of fluids (Duval, 1995; Kien et al., 1998; Garrido et al., 
2006; Magdesian, 2015b).  
Hypertonic saline has been used for some time to help balance fluid and electrolyte’s losses in 
severely burnt patients and to reduce intracranial pressure in traumatic brain injury, many times 
as pre-hospital treatments (Fettman, 1985; Kien et al., 1998; Magdesian, 2015b). 
The expansion in plasma volume and improved cardiac output promote the redistribution of 
blood flow from peripheral beds to vital organs and the reestablishment of microhemodynamics, 
reducing tissue lesions due to ischemia or inflammatory processes. There seems to be a bigger 
increase in blood flow to organs like heart, kidney, liver and intestines after treatment with 
hypertonic solutions when compared to isotonic solutions (Schmall, 1989; Kien et al., 1998).  
The improved kidney perfusion and higher plasma sodium concentration after HSS infusion lead 
to a shorter time to urination, increased urinary frequency and more diluted urine, compared to 
treatment with isotonic crystalloids, which is believed to act as a protective effect against renal 
failure associated with hypoperfusion (Fielding & Magdesian, 2011). With the normalization of 
renal function, HSS is also believed to restore the renal interstitium osmolality and the 
countercurrent mechanisms by providing the needed electrolytes (Fettman, 1985). This effect 
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will help avoid medullary washout (Fettman, 1985). Medullary washout describes the loss of the 
medullar interstitium osmolality gradient, consequent inability to concentrate urine after 
restoration of renal blood flow and increased diuresis following high-volume fluid administration 
(Schott II, 2010; Magdesian, 2015b). 
Treatment with hypertonic saline is contraindicated in the presence of hypernatremia, 
hyperchloremia or hyperosmolarity as these are already intrinsic risks to the administration of 
HSS (Fettman, 1985; Kien et al., 1998; Magdesian, 2015b). 
Due to its low pH and absence of a buffer component, some clinicians worry about a possible 
iatrogenic acidosis caused by the administration of hypertonic saline. But according to Constable 
(2003) the decrease in pH caused by HSS in large animals is less than 0.08 units and it lasts 
little time making this a safe solution in terms of acid-base balance. 
While treatment with hypertonic saline solution is indicated in some cases of hemorrhagic shock, 
the presence of uncontrolled hemorrhage excludes the possibility of using HSS as these 
solutions are reported to increase bleeding and reduce clot stabilization (Kien et al., 1998; 
Kreimeier & Messmer, 2002; Magdesian, 2015b). 
Even though the benefits of hypertonic solutions are numerous one should have in mind that the 
effects of hypertonic saline solutions are of short duration and work at the expenses of the 
body’s fluid reserves. There’s some concern about giving hypertonic solutions to dehydrated 
patients since these may have intracellular fluid deficits and may not be able to compensate the 
hyperosmolar conditions. In such situations Magdesian (2015b) advises the administration of 
isotonic crystalloids prior or simultaneously to the HSS infusion. In patients with mild or no signs 
of dehydration, the administration of hypertonic solutions should be followed by adequate 
amounts of isotonic or hypotonic IV fluids or the patient should be allowed to drink ad libitum 
(Magdesian, 2015b).  
1.2.4. Crystalloids Vs Colloids 
Colloids are solutions containing large molecular weight molecules and can be divided in 
natural: plasma (the most used in equine medicine), whole blood and albumin; or synthetic: 
hydroxyethyl starch solutions (the most used in equine medicine), dextran, gelatin and 
polymerized hemoglobin (Magdesian, 2015b). There is an ongoing debate in the medical field 
about the fluid choice for resuscitation purposes in both human and veterinary medicine 
(Pantaleon, 2005; Chan, 2008; Magdesian, 2015b; Cazzolli & Prittie, 2015). Both crystalloids 
and colloids present advantages and disadvantages in their use and numerous studies have 
been conducted to clarify which one overcomes the other with no obvious conclusions in either 
human or veterinary medicine (Chan, 2008; Magdesian, 2015b). Due to the elevated price of 
colloids and lack of obvious benefits over crystalloids, the last ones are usually preferred over 
the first (Magdesian, 2015b). Although colloid solutions carry increased risks of anaphylactic 
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shock, coagulopathies and acute renal failure, (Chan, 2008; Cazzolli & Prittie, 2015; Magdesian, 
2015b) they also provide a bigger oncotic pressure to plasma, having longer lasting effects on 
plasma expansion than crystalloids (Magdesian, 2003; Chan, 2008). Due to the dilutional effect 
of isotonic crystalloids that leads to loss of intravascular oncotic pressure, the use of colloids is 
advised in case of augmented capillary permeability and risk of edema formation (Cook & Bain, 
2003; Magdesian, 2003; Pantaleon, 2005). However, the clinician should use colloids 
conservatively in patients with SIRS or severe trauma whose capillary permeability may be such 
that there is extravasation of colloids to the interstitium, potentiating interstitial edema formation 
(Magdesian, 2015b) 
Renal failure has not yet been reported in horses receiving hydroxyethyl starch, commonly 
known as hetastarch, and to the moment there are no studies relating increased mortality with 
colloid treatment in equine medicine. However, a recent meta-analysis of 38 clinical trials in 
humans, gathering more than 10.000 patients, questioned the safety of this solution. The doubt 
about hetastarch’s safety was further aggravated when hydroxyethyl starch was in fact 
correlated with increased mortality and renal failure after seven trials stating the opposite were 
removed from this meta-analysis due to “retraction of the original studies because of scientific 
misconduct on the part of the lead author” (Magdesian, 2015b).  
The use of crystalloids associated with colloids has proved to be useful in multiple situations 
(Pantaleon, 2005). A study conducted in an infant animal model of hypovolemic shock 
concluded that the effects of resuscitation with 3% hypertonic saline solution or with a 
combination of 3% hypertonic saline colloid and 5% albumin resulted in similar hemodynamic 
improvements with longer lasting effects for the hypertonic saline colloid (Urbano et al., 2012). 
The association of colloids and hypertonic crystalloids produces a synergetic effect as colloids 
maintain appropriate plasma oncotic pressures while hypertonic crystalloids draw water into the 
vessels, conserving the plasma expansion effect for longer (Pantaleon, 2005). Adding colloids to 
crystalloid solutions will also reduce the risk of edema formation whereas the crystalloids may 
exert some protective effect against kidney damage and replace interstitial fluid losses 
(Magdesian, 2003, 2015b).  
1.3. Central Venous Pressure  
Measuring the central venous pressure is a simple, minimally invasive and useful method of 
assessing a patient’s circulatory status and cardiac function, especially when it comes to critical 
care, as well as a helpful way of deciding about and monitoring the response to treatment.  
In simple terms, the CVP is the pressure exerted by the blood inside the thoracic cranial vena 
cava and it reflects the relation between volemia, venomotor tone and cardiac function, or the 
blood volume of the venous compartment, the volume capacity of the vessel and the diastolic 
pressure of the right ventricle (Magdesian, 2004). 
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In the human body approximately 70% of total blood volume is contained in the venous system 
while only 18% is in the arterial system and the remaining in terminal arteries and arterioles 
(Gelman, 2008). In horses the distribution is about 60% in the venous system, 15% in arterial 
system and the remaining in terminal circulatory vessels (Poole & Erickson, 2008). Due to their 
high capacitance and high compliance, veins serve as the body’s main blood reservoir and are 
responsible for maintaining filling pressure in the right heart trough minimal changes in 
transmural pressure, making them easily adaptable to changes in blood volume (Gelman, 2008).  
To be clear how the CVP influences the cardiac output (CO) and circulatory status, concepts 
such as venous resistance (VRst), venous return (VR) and mean circulatory filling pressure 
(MCFP) must be understood first.  
Venous resistance is simply the force that opposes blood flow when going through the systemic 
venous circulation and it is dependent of the length and diameter of the vessel ( Gelman, 2008; 
Frandson, Wilke, & Fails, 2009; Bressack & Raffin, 2016;).  
Gelman, 2008, describes the mean circulatory filling pressure as the blood pressure inside any 
vessel of the circulatory system in case the heart stopped beating for a small fraction of time 
and, therefore, no blood would be flowing from or to the heart and the pressure inside all vessels 
would be the same.  
Venous return is a simple concept used to describe the amount of blood that reaches the right 
ventricle during diastole. According to Starling’s law of the heart, the larger the venous return the 
larger the stroke volume ejected during the systole, meaning, the bigger is the cardiac output 
considering the same heart rate (Elliott & Bowen, 2010). 
The venous return can be considered as the difference between the mean circulatory filling 
pressure and central venous pressure divided by the venous resistance (Gelman, 2008): 
VR = (MCFP-CVP) / VRst 
Although, in theory, the venous return can be influenced by the venous resistance, in physiologic 
conditions this parameter doesn’t change much and is relatively small making it so that the CO 
is mainly influenced by the VR and the VR can be increased only by increasing the MCFP or 
decreasing the CVP  (Gelman, 2008). 
Although the previous statement seems contradictory since it’s known that an increase in CVP 
will improve the CO in a normal heart, the fact is that, upon administration of fluids or 
venoconstrictors, the mean circulatory filling pressure will, too, suffer an increase equal or bigger 
than the central venous pressure and, therefore, the total VR will rise as well (Gelman, 2008). 
The central venous pressure measurement is traditionally made inside the thoracic cranial vena 
cava although other possible locations such as the jugular vein, pulmonary artery and right 
atrium have also been reported (Wilsterman, Hackett, Rao, & Hackett, 2009).  
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Figure 12: Neutral position of the head. Notice how the 
mare is relaxed and no restraining is being used. If 
repositioning of the head was necessary, holding the lead 
rope in the right position would be enough for most of the 
cases. 
Different procedures for measuring CVP have been described. Commercial catheters designed 
especially for the measurement of central venous pressure are available to sizes up to 90 cm of 
length but Fielding, Balaam, and Sprayberry (2004) demonstrated a new alternative for adult 
horses using a sterile 55 cm polyethylene or polypropylene tubing filled with heparinized fluid 
passed through a regular 10 or 14 gauge venous catheter. For average-sized neonatal foals a 
20-30 cm jugular catheter is usually suitable (Magdesian, 2004). The catheter is then attached to 
a measuring device like a water manometer or to an electronic pressure transducer connected 
to a monitor. Attention should be payed to air within the lines or manometer and eventual 
catheter obstructions or kinking since these will created artificially high values  (Magdesian, 
2004).   
While the water manometer is more portable and fairly inexpensive compared to the electric 
pressure transducer and monitor, it is less precise and will only allow for intermittent readings 
whereas the second will allow for more accurate values and a continuous monitoring (Tennent-
Brown, 2015). Measurements made in mmHg can be easily converted to cmH₂O by multiplying 
the value by 1,36. 
Ideally, the CVP measurements are referenced to the right atrium and 
the zero mark on the water manometer or pressure transducer should 
be leveled to its height. Externally in a standing horse, this corresponds 
to the point of the shoulder and in a recumbent horse it corresponds to 
the tip of the manubrium. It is important that this mark remains the same 
throughout different measurements so a clipped line or other kind of 
mark on the horse’s shoulder or taping the measuring devise to a 
height-fixed object are practical solutions (Figure 11) (Tennent-Brown, 
2015).  
Head should be kept in a neutral position, ideally with the tip of the nose 
at shoulder point height, and stay constant in between measurements. 
Efforts should be made to restrain the horse as little as possible and 
nose twitches or other type of containing instruments should be avoided 
(Figure 12) (Norton et al., 2011; Tennent-Brown, 2015). 
Large oscillations probably mean the catheter is inserted in the right 
ventricle or pulmonary artery in which case it 
should be pulled back until the oscillations are 
small and only due to respiration (Magdesian, 
2004). In case the catheter is connected to a 
pressure transducer and monitor, the 
waveforms and pressure values can provide 
Figure 11: To avoid 
clipping a line in the 
horse's shoulder a strip 
of white tape (arrow) 
marks the "zero" for the 
measuring devise. This 
technique only works if 
the skin is dry and for a 
short period of time. 
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information about the location of the catheter tip (Figure 13) (Tennent-Brown, 2015). The correct 
positioning of the catheter can also be confirmed by echocardiography (Wilsterman et al., 2009) 
or, in case of neonatal foals, by portable thoracic radiographs (Tennent-Brown, 2015). 
It is expected for the CVP reading to slightly decrease during inspiration and to increase during 
expiration as intrathoracic pressure falls and rises, respectively (Cook & Bain, 2003). This 
oscillation is a helpful way to confirm that the catheter tip is, in fact, intrathoracic. Higher CVP 
values are also expected in recumbent horses during anesthesia, specially lateral recumbency 
(Klein & Sherman, 1977) and during positive pressure ventilation (Gelman, 2008), however, in 
this case, the higher values will be reached during inspiration instead of expiration (Magdesian, 
2004). In any case, CVP readings should be 
done at the end of expiration (Magdesian, 
2004). 
Sedation is sometimes required to properly handle and examine a horse. In these cases 
xylazine is the advised drug since it seems to have minimal influence on CVP, while 
acepromazine may decrease its readings (Klein and Sherman 1977; Fielding, Balaam, and 
Sprayberry 2004). 
Measuring CVP is indicated in the assessment of patients presenting with hypovolemia, right-
side heart failure and hypooncotic states, and to monitor the response to fluid therapy, patients 
in risk of edema formation and patients in acute stages of altered cardiac contractility 
(Magdesian, 2004). 
Numerous studies have been carried out to establish the normal CVP values for adult horses, 
being that an interval ranging from 7,5 ± 0,9 to 12,0 ± 6,0 cmH₂O (Magdesian, 2004) is 
considered normal. On the other hand, a study done to evaluate the repeatability, reproducibility, 
and effect of head position on CVP measurements in standing healthy adult horses had mean 
CVP values of 9,4 ± 3,6 cmH₂O and 9,56 ± 4,2 cmH₂O on two different experiments (Norton et 
al., 2011). Another study meant to analyze the effects of hypohydration on CVP and splenic 
volume in healthy adult horses obtained basal CVP values ranging from 6,0 to 20,7 cmH₂O, with 
a mean of 11,6 cmH₂O (Nolen-Waltson et al., 2011).  These results suggest that CVP values 
outside the expected interval may still be considered normal. Values for neonatal foals on their 
first 2 weeks of live range from 2,8 to 12,0 cmH₂O (Magdesian, 2004). Consequently, much 
more information can be obtained by relating the patient’s CVP values to their clinical 
presentation and by evaluating each individual’s CVP variation along time, either by serial or 
continuous measurements, instead of relying on a single measurement (Magdesian, 2004; 
Tennent-Brown, 2015).  
A significant number of factors can affect the values of CVP readings. Some are simply 
physiological while others may indicate more serious events and be a reason for concerning 
Figure 13: Different waveforms and pressure values 
shown on the monitor of the pressure transducer 




Norton et al., 2011, proved that head height in adult horses had a significant effect on CVP, 
being that the elevated head position would decrease the CVP in 2,0 ± 6,5 cmH2O and the 
lowered head position would increase it in 3,7 ± 5,5 cmH2O.  
Although normal CVP values do not necessarily indicate euvolemia, low or negative values are 
most likely an indication of hypovolemia or increased vasodilation (Magdesian, 2004). When 
monitoring fluid therapy, the absence of an increase in CVP readings after a fluid bolus may be 
a sign that the hypovolemia still stands whereas an increase bigger and faster than expected is 
most likely a sign of fluid overload (Magdesian, 2004) or cardiac failure (Gelman, 2008). On the 
other hand, fluid overload may be compensated by accumulating blood in the splanchnic 
circulation without altering CVP values (Gelman, 2008). 
Increases in CVP can also be caused by pericardia/pleural infusion, pneumothorax, pulmonary 
hypertension, venoconstriction or increased intrathoracic or intraabdominal pressure (Gelman, 
2008; Magdesian, 2004). 
One of the first mechanisms the body activates when trying to cope with hypovolemia is to shift 
the blood located on the splanchnic circulation onto the main venous circulation, only upon the 
exhaustion of this blood reserve the central venous pressure will start dropping. In humans, a 
clearly low CVP may represent a blood volume loss greater than 10-12% (Gelman, 2008).  
In contrast, in cases of mild hypovolemia, the CVP can also drop in an attempt to decrease the 
MCFP-CVP gradient described above and consequently increase the venous return and cardiac 
output (Gelman, 2008).  
An experimental model of acute blood lost showed that the decrease in CVP was noted 
significantly prior to the increase in heart rate, which stands once more for the importance of this 
tool in the early assessment of the patient’s circulatory status (Magdesian, Fielding, Rhodes, & 
Ruby, 2006).  
Situations of venodilation or blood sequestration in the splanchnic circulation also cause the 
CVP to decline (Gelman, 2008). 
It is important to remember the innumerous coping mechanisms of the circulatory system and 
how an appropriate CVP is important for the cardiovascular function. The body puts all efforts in 
maintaining homeostasis which may lead to the presence of normal CVP values even in 
situations of serious hemodynamic derangements, making so that some authors only consider 
extreme CVP values to be noteworthy and affirm that it is impossible to build a correlation 
between CVP and circulating blood volume (Gelman, 2008).  
1.4. Noninvasive arterial blood pressure 
Even though blood flow is the actual factor that limits tissue perfusion, its direct measurement is 
not practicable in the day to day practice. Therefore, arterial blood pressure is the best way to 
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estimate blood flow and, as long as the vessel’s compliance and resistance are normal, the 
correlation between both is generally good (Magdesian, 2004; Tennent-Brown, 2015). 
Arterial blood pressure is simply described as the product of cardiac output and the systemic 
vascular resistance or total peripheral vascular resistance (TPR) and is usually represented as 
mean arterial pressure (MAP), although it is also possible to obtain systolic and diastolic values  
(Frandson, Wilke, and Fails 2009; Magdesian 2004):  MAP = CO x TPR. 
In opposite to veins, arteries have very low compliance and function as a reservoir of blood 
under pressure, being that arterioles contribute the most for the systemic vascular resistance. 
This way, arterial blood pressure is the balance between the force pushing blood into the 
arteries, this is, the systole, and the force that opposes the blood from exiting the arteries, 
meaning, the resistance created by the arterioles (Frandson, Wilke, et al., 2009).  
Knowing that blood pressure is fundamental for the appropriate perfusion of tissues, the body 
holds innumerous mechanisms for the regulation of blood volume and arterial blood pressure. 
The kidneys are the organs whose function have a bigger impact in the regulation of the 
circulating blood volume by the activation of the renin-angiotensin-aldosterone system. This 
system promotes vasoconstriction and reduces urinary excretion of water and sodium chloride 
resulting in an increase in arterial pressure and blood volume (Frandson, Wilke, et al., 2009).  
Other mechanism capable of regulating blood pressure and volume include the arterial 
baroreceptors reflexes, responsible for changes in heart rate, cardiac contractility, arteriolar 
constriction and venoconstriction; epinephrine and norepinephrine upsurges under stressful 
situations, leading to increases in heart rates and constriction of smooth vascular muscle; atrial 
natriuretic peptides that increase the excretion of sodium chloride and water by the kidneys and 
promote the relaxation of the arterioles in response to increases in atrial filling pressures; and 
endothelin and nitric oxide released by endothelial cells, with arteriolar vasoconstrictive and local 
vasodilating properties respectively (Frandson, Wilke, et al., 2009). 
Several techniques are known and used to measure arterial blood pressure and can be divided 
in either invasive or direct and noninvasive or indirect methods. 
Direct measurements are normally performed by catheterization of the transverse facial artery in 
adult horses or the great metatarsal artery in foals (Magdesian, 2004). Other locations for adult 
horses catheterization include the facial artery and the dorsal metatarsal artery (Taylor & Clark, 
2007) and for foals are the radial and caudal auricular arteries (Magdesian, 2004). The catheters 
are connected to an electronic pressure transducer with monitor or to an 
aneroid manometer leveled with the sternum. Direct blood pressure 
requires more technique, especially in situations of hypotension and can 
result in complications such as hematomas and septic or thrombotic 
complications, it can also be harder to maintain the catheter in place in 
Figure 14: Inflatable cuff 
placement for NIBP 
measurements on the 




an active animal (Magdesian, 2004; Taylor & Clark, 2007; Tennent-Brown, 2015). On the other 
hand, this technique allows for continuous monitoring and has an improved accuracy compared 
to the noninvasive method, especially in severe low-stroke volume or vasoconstrictive states, 
making it more appropriate for monitoring critically-ill patients (Fielding and Magdesian 2015; 
Magdesian 2004). 
Indirect or noninvasive blood pressure (NIBP) can be measured through different methods being 
that the most commonly used in equine medicine are the oscillometric sphygmomanometry and 
the Doppler methods (Robertson, 2010). The oscillometric sphygmomanometry method records 
systolic, diastolic and  mean arterial pressures through an inflatable cuff, usually placed around 
the coccygeal artery on the base of the tail (Figure 14) or around the dorsal metatarsal artery on 
the metatarsus (Hardy, 2010; Magdesian, 2004). As the cuff deflates, an oscillometric 
automated sphygmomanometric monitor records the changes in oscillation generated by the 
changes in blood flow (Corley, 2008b; Hardy, 2010). These oscillations start when the cuff’s 
pressure reaches systolic pressure, at mean arterial pressure the oscillations are maximal and 
then reduce until they disappear at diastolic pressure (Hardy, 2010). A great number of 
oscillometric monitors is fabricated for human use which can represent a problem when 
measuring over the horse’s slower heart rates (Corley, 2008b; Robertson, 2010). Therefore, if 
the heart rate displayed on the monitor does not match the horse’s heart rate, the readings 
should be discarded (Corley, 2008b; Magdesian, 2004). 
The Doppler method uses a piezoelectric probe that detects the blood flow, amplifies it and 
converts it in an audible signal (Hardy, 2010; Robertson, 2010). The probe must be placed over 
the coccygeal artery, just distally to an inflated cuff that’s occluding the artery. The cuff must be 
attached to a sphygmomanometer. As the cuff deflates the first sounds corresponds to the 
systolic blood pressure (Robertson, 2010). Doppler units that detect arterial wall motion (instead 
of blood flow) are also able of measuring the diastolic pressure (Magdesian, 2004). This method 
is not accurate at measuring mean arterial pressures and it leads to considerable errors in 
dorsally recumbent horses (Hardy, 2010; Robertson, 2010). 
The actual part of the cuff that is inflated is called the bladder (Figure 15) and it is important to 
have in account the bladder width to tail girth ratio (BW/TG) when aiming for the most accurate 
measurements (Corley, 2008b; Parry, McCarthy, & Anderson, 1984). In cases where the bladder 
is too wide, the readings will be lower than reality whereas if the bladder is too narrow the 
readings will be falsely high (Corley, 2008b; Magdesian, 2004). Parry, McCarthy, and Anderson, 
(1982) showed that the BW/TG ratio for optimal accuracy of systolic blood pressure should be of 
0,34 while for diastolic blood pressure it 
should be of 0,98, in adult horses. For an 
accurate measurement of MAP, Magdesian 
Length	
Width	
Figure 15: Inflatable cuff, bladder and bladder width and 
length. Adapted form:  http://drrajivdesaimd.com/?paged=20 
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(2004) affirms that the BW/TG ratio should be of 0,2 to 0,25 for the tail and 0,4 to 0,5 for the 
limb. The bladder’s length will also play a role in arterial blood pressure measurements and it 
should be of about 80% of the circumference of tail or limb (Magdesian, 2004). Cuffs that are too 
loose or too tight around the appendage will also provide falsely low or high measurements, 
respectively (Magdesian, 2004).  
Arterial blood pressure from the coccygeal artery can be corrected to the level of the heart or 
stated as uncorrected “coccygeal values”. In standing horses, coccygeal blood pressure tends to 
be 15-20 mmHg lower than the corrected value since the artery is elevated is relation to the 
heart. The opposite happens in horses in dorsal recumbency. The most important factor to have 
in consideration is the consistency among measurements, more than their correction for height 
or not (Magdesian, 2004).  
When measuring NIBP it’s important to follow some recommendations for a better accuracy of 
the technique and higher reliability and consistency of the results obtained. The horse’s head 
should be kept in a neutral position like the one explained for CVP measurements (Magdesian, 
2004). Stress and excitement ought to be reduced as much as possible and the animal should 
be allowed to get used to the inflation and deflation of the cuff before one begins to record the 
given values as some horses might contract their coccygeal muscles for the first couple of cycles 
(Magdesian, 2004; Parry et al., 1984). 
A survey of resting blood pressure in clinically normal horses found significant differences in 
diastolic and systolic blood pressure between horses considered nervous/timid, normal/quiet 
and very quiet (Parry et al., 1984). The same survey also reported significantly higher values for 
Thoroughbreds when compared to Standardbreds and hacks. A different study also found 
invasive and noninvasive arterial blood pressures of 24 hour old Thoroughbred foals to be 
significantly higher than those of same age pony foals (Franco, Ousey, Cash, Rossdale, & 
Silver, 1986). 
Parry et al. (1984), after surveying 296 clinically normal adult horses for resting coccygeal blood 
pressure, obtained uncorrected coccygeal values of 112,1 ± 16,5 mmHg for systolic pressure, 
77,3 ± 14,3 mmHg for diastolic pressure and 88,9 ± 14,4 mmHg for MAP. According to 
Magdesian (2004) and Hardy (2010), normal NIBP values for adult horses are	 111,8 ± 13,3 
mmHg, ranging from 79 to 145 mmHg, for systolic pressures and 67,7 ± 13,8 mmHg, ranging 
from 49 to 106 mmHg, for diastolic pressures. A minimal MAP of 50 to 60 mmHg is essential for 
proper tissue, particularly cerebral, lung and coronary, perfusion (Magdesian, 2004). 
Gay et al. (1977) evaluated the relation between systolic NIBP using the Doppler method and 
prognosis for 33 horses that underwent colic surgery. The authors showed how eight out of the 
nine horses that died had sistolic blood pressures between 59 and 99 mmHg, and the remaining  
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was a large mare in late pregnancy with a systolic blood pressure of 130 mmHg. From the 
surviving group only four horses had blood pressures inferior to 99 mmHg.  
Parry, Anderson, & Gay (1983) also found a positive relation between low blood pressure and 
death in horses with colic, where 12  out of 13 (92%) of the horses with a systolic pressure 
inferior to 60 mm Hg died while only two out of 57 (4%) of the horses with systolic blood 
pressure above 100 mm Hg had the same outcome. In the same study, the mean systolic and 
diastolic pressures were 132,3 ± 3,8 mm Hg and 87,6 ± 2,9 mmHg, respectively, for the 
surviving group (n=66) versus 61,7 ± 8,4 mm Hg and 41,8 ± 6,9 mmHg for the non-surviving 
group (n=20).  
Low arterial blood pressure in cases of abdominal colics can reflect a set of condictions such as 
hypovolemia, reduction of peripheral vasculature resistance, endotoxemia, SIRS and acid/base 
imbalances (Gay et al., 1977). High arterial blood pressures in abdominal pain are atributed 
mainly to pain and the presence of hypertension may be indicative that toxemia and 
hypovolemia haven’t settled yet (Gay et al., 1977). 
Probably due to peripheral vasoconstriction, noninvasive blood pressure measurements in 
hypovolemic patients may be falsely low, which makes direct blood-pressure measurements to 
probably be more accurate (Cook & Bain, 2003). 
1.5. Oxygen delivery and uptake  
Oxygen delivery (DO₂) is the quantity of oxygen delivered to the tissues from the heart per unit 
of time and it can be understood as the product of cardiac output (CO in mL/min) or cardiac 
index (CI in mL/Kg/min) and the arterial content in oxygen (CaO₂ in mL/dL).  
The CaO₂ is normally distributed 98,5% in hemoglobin (Hb) and 1,5% dissolved or free (Divers, 
2003a). Being that the dissolved portion of O₂ is so small we can calculate, with some accuracy, 
the CaO₂ as the product between the concentration of hemoglobin in the blood ([Hb] in g/dL), 
the quantity of oxygen transported by unit of fully saturated hemoglobin - which varies slightly 
according to the reference (1,34 mLO₂/g Hg (Magdesian, 2004) to 1,36 mLO₂/ g Hb (Allen & 
Holm, 2008)) - and the amount of oxygen-saturated hemoglobin known as oxygen saturation 
(SaO₂ %) (Allen & Holm, 2008): 
DO₂ (mL/min) = CO x CaO₂ = (Stroke Volume x Heart Rate) x ([Hb] x 1,35 x SaO₂) 
For a more accurate calculation of the CaO₂, Magdesian (2004), includes the arterial partial 
pressure of oxygen (PaO₂ mmHg), meaning the fraction of the total arterial gas pressure exerted 
by oxygen, and the free or dissolved portion of oxygen (0.0031) in the equation:  
CaO₂ (mL/dL) = [Hb] x 1,34 x SaO₂ + (PaO₂) 0,0031 
31	
	
Two studies established normal values of DO₂ for healthy adult ponies and foals as 9,45 ± 1,92 
mL/Kg/min and 31 mL/Kg/min respectively (Magdesian, 2004).  
Oxygen uptake or consumption (VO₂) and oxygen extraction ratio (OER) represent the amount 
of oxygen that is being extracted from the microcirculation blood and used by tissues as an 
exact value or a percentage of DO₂, respectively (Magdesian, 2004). The OER is about 23 to 
30% of the DO2 (Divers, 2003a) and, under normal conditions, it stays constant under a large 
interval of DO₂ values since these are always higher than the VO₂ (Allen & Holm, 2008; 
Magdesian, 2004).  
The VO₂ can be calculated as the difference between the arterial and venous oxygen content 
(CvO2) multiplied by the CO (Magdesian, 2004): 
VO₂ (mL/min) = (CaO₂ - CvO₂) x CO 
The CvO₂ is calculated the same way as the CaO₂ but using the venous oxygen saturation and 
concentration values (Magdesian, 2004). 
Two studies established normal values of VO₂ for healthy adult ponies and foals as 2,05 ± 0,74 
mL/Kg/min and 5,6 mL/Kg/min respectively (Magdesian, 2004).  
To calculate the oxygen extraction ratio the CO does not need to be known (Magdesian, 2004): 
OER (%) = ([CaO₂ - CvO₂] 100) / CaO₂ 
A study done in five healthy foals determined the OER as 18,0 ± 0,02% (Magdesian, 2004). 
VO2 can become dependent of the DO₂ if the last decreases below a certain point like in 
anemia, hypovolemia, low CO, etc. (Magdesian, 2004). In these cases, tissues respond by 
increasing the OER (Allen & Holm, 2008). When the DO₂ reaches a point where the OER can no 
longer be increased to secure appropriate tissue oxygenation and aerobic metabolism, called 
critical DO₂ (Allen & Holm, 2008), the affected tissues enter a state of dysoxia (Magdesian, 
2004) and lactate production is initiated. 
1.6. Lactate 
Lactate measurements have been used since the mid-1970’s in equine critical care but real 
advances concerning the use of lactate in this area have only been made in the last 20 years 
(Franklin & Peloso, 2006). Lactate is the ionized form of lactic acid and a fairly quick and easy 
biomarker to measure in either whole blood or plasma. It can provide important information 
about peripheral perfusion and O₂ delivery to the tissues (Magdesian, 2004), as well as help 
decide about diagnosis and treatment options. In addition, lactate is also an important indicator 
in equine medicine when it comes to therapy monitoring and prognosis evaluation, particularly in 
neonates and colic patients (Allen & Holm, 2008; Radcliffe, Buchanan, Cook, & Divers, 2015; 
Tennent-Brown, Wilkins, Lindborg, Russell, & Boston, 2010).  
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Glycolysis is an anaerobic process that all cells are able of performing, being that brain, liver and 
skeletal cells are the ones with higher rates. Glycolysis is the first step of glucose metabolism 
and it happens in the cell’s cytoplasm (Allen & Holm, 2008). The result of each molecule of 
glucose metabolized are two molecules of pyruvate, two molecules of nicotinamide adenine 
dinucleotide (NADH) (by reduction of the enzyme cofactor NAD⁺), two molecules of adenosine 
triphosphate (ATP), two molecules of water and two hydrogen ions (Nelson & Cox, 2013):  
C₆H₁₂O₆ + 2NAD⁺ + 2ADP + 2Pᵢ → 2CH₃COCOO⁻ + 2NADH + 2ATP + 2H₂O + 2H⁺ 
The pyruvate molecules resulting from glycolysis, still contain most of the biologically available 
energy from the glucose molecule. Under normal O2 conditions, in the mitochondria of 
eukaryotic cells, this energy can be extracted by oxidizing the pyruvate to acetate which then 
enters the citric acid cycle and is oxidized to CO₂ and H₂O (Nelson & Cox, 2013). Still in the 
mitochondria, NADH is reoxidized to NAD⁺ by transferring their electrons to the respiratory chain 
which provides energy for the production of ATP by mitochondrial oxidative phosphorylation 
(Nelson & Cox, 2013): 
The entire oxidation of a molecule of glucose results in the production of 38 molecules of ATP 
(Allen & Holm, 2008; Nelson & Cox, 2013). 
 When a cell does not possess mitochondria, such as erythrocytes, retina or brain cells (Nelson 
& Cox, 2013), the pyruvate is converted into lactate by the enzyme lactate dehydrogenase 
(LDH) and, at the same time, the NADH is oxidized back to NAD+ allowing for glycolysis to 
continue (Allen & Holm, 2008):  
CH₃COCOO⁻ + NADH + H⁺ ↔ CH₃CHOHCOO⁻ + NAD⁺ 
Cells from liver, kidney and heart are capable of using the lactate produced by these cells and 
other tissues such as extremely active skeletal muscle as a source of energy. This process is 
called the Cori cycle (Allen & Holm, 2008; Nelson & Cox, 2013). The lactate is transported to 
these tissues and converted back to pyruvate which then enters the cell’s mitochondria to 
produce ATP. In the liver and kidney, lactate can also be transformed into glucose through 
gluconeogenesis and either stored under the form of glycogen or released into the blood to be 
used by other tissues (Allen & Holm, 2008). Under normal conditions, the metabolism of lactate 
consumes hydrogen ions and generates carbon dioxide that is in equilibrium with bicarbonate. 
Therefore lactate metabolism has a final alkalinizing effect (Magdesian, 2004). 
Glycolysis is a much faster but less efficient method of producing energy than the aerobic 
metabolism (Allen & Holm, 2008). Anaerobic metabolism requires about 18 times more glucose 
to be metabolized to produce the same amount of ATP as it would under aerobic conditions 
(Nelson & Cox, 2013).  
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In the absence of appropriate O₂ levels in the tissues, termed hypoxia, the cell must find an 
alternative way of reducing NADH to NAD⁺ (Nelson & Cox, 2013). This is achieved by the 
reduction of pyruvate to lactate by LDH as described before for cells that don’t have 
mitochondria.  
The reduction of NAD⁺ to NADH and the consumption of ATP result in the production of 
hydrogen ions which start to accumulate instead of being consumed by oxidative 
phosphorylation, as would happen in aerobic conditions (Allen & Holm, 2008).  
The capacity of converting lactate to pyruvate or glucose will also be affected by the level of 
hypoxia present in such tissues (Allen & Holm, 2008). As hypoxia persists, lactate will start to 
accumulate inside the cell until it reaches concentrations high enough for it to start crossing the 
cell membrane into the blood stream (Allen & Holm, 2008). When the production of lactate by 
the cells exceeds the clearance rates, mainly by the liver and kidneys, hyperlactemia develops ( 
Tennent-Brown et al., 2010; Radcliffe et al., 2015). At first the hydrogen ions are titrated by body 
buffers but, as these get depleted, acidemia starts developing alongside with lactate 
accumulation (Allen & Holm, 2008).  
The lactate produced by anaerobic cellular metabolism is the levorotatory isomer, better known 
as L-lactate. 
D-lactate is the lactate isomer produced by the glucose metabolism of bacteria since 
mammalian cells do not have the D-lactate dehydrogenase enzyme (Nappert & Johnson, 2001).  
Although hyperlactemia due to increases in D-lactate is rare in monogastric mammals, D-lactic 
acidosis has been reported in humans with short bowel syndrome, in a cat with exocrine 
pancreatic insufficiency and intestinal bacteria overgrowth (Allen & Holm, 2008) and cats with 
Diabetes Mellitus (Nappert & Johnson, 2001). D-lactate increases are more significant in 
ruminants. D-lactic acidosis has been shown to be common in calves with acidosis due to 
diarrhea and in adult ruminants subjected to grain overload where the production of D-lactate by 
Lactobacillus spp overcomes the production of L-lactate (Nappert & Johnson, 2001).  
D-lactate is excreted in the urine although renal clearance is much higher for the L isomer 
(Nappert & Johnson, 2001). Some D-lactate can be transformed in pyruvate and then oxidized 
or used for gluconeogenesis (Nappert & Johnson, 2001). 
Commercial lactate analyzers are only able of detecting the L-lactate isomer, therefore, 
increases in D-lactate should be suspected in patients with gastrointestinal disease and acidosis 
but with normal L-lactate levels (Allen & Holm, 2008). This is due to the production of D-lactate 
by intestinal bacteria, mainly from the large intestine, which is absorbed and detected in the 
blood pH (Franklin & Peloso, 2006). 
Lactate concentrations can be measured using whole blood or plasma in commercial analyzers, 
preferably those that have been validated for the species in focus (Magdesian, 2004; Corley, 
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2008b). One should be aware that lactate concentrations tend to be lower when using a whole 
blood sample, most likely due to the dilutional effect of the erythrocytes, which are poorer in 
lactate than plasma (Radostits, Gay, Hinchcliff, & Constable, 2007). Other lactate analyzers 
work by measuring colorimetric changes which can be affected by high hematocrits (Corley, 
2008b). 
In situations where a commercial lactate analyzer is not available, given that the concentration of 
plasma proteins is normal, plasma lactate concentration can be known with relative accuracy by 
calculating the anion gap (AG) in adult horses (Smith, 2009):  
AG = (Na⁺ + K⁺) – (Cl⁻ + HCO₃⁻) 
Still, the estimation of lactate concentration through the AG should be used with caution since 
the AG can also be elevated in cases of azotemia and decreased in hypoalbuminemia situations 
(Tennent-Brown, 2015). 
Increases in L-lactate may be due to several causes. In veterinary medicine hyperlactemia can 
be divided into two categories: type A and type B (Magdesian, 2004; Allen & Holm, 2008; 
Radcliffe et al., 2015). 
Radcliff et al, 2015, defined type A hyperlactemia as the one resulting from tissue hypoxia 
secondary to deficient Do₂ and type B hyperlactemia when it’s caused by mitochondrial 
dysfunction, altered carbohydrate metabolism or decreased lactate clearance.  
A more thorough description of the possible causes of hyperlactemia separated into different 
categories is presented in Table 3. 
Table 3: Types of lactic acidosis in veterinary medicine. Adapted from Magdesian (2004), Allen and Holm 
(2008) and Radcliffe (2015). 






































The clinical presentation of hyperlactemia is the one of the resulting metabolic acidosis but 
usually the clinical signs of the underlying condition causing the increases in lactate are the most 
evident (Smith, 2009).   
In horses, the most common causes for hyperlactemia are consequence of cellular hypoxia 
(type A) in cases of hypovolemia, hypotension, low arterial O₂ content and hypermetabolic 
states such as increased muscle activity, sepsis or seizures (Magdesian, 2004).  
Activated white blood cells and catecholamine increases during SIRS, sepsis-induced 
inflammatory mediators, inhibition of pyruvate dehydrogenase, glucose infusions and systemic 
alkalosis all contribute for the production of lactate under aerobic conditions for multiple reasons 
(Magdesian, 2004).  
One study showed that postpartum and lactating mares may have slightly elevated lactate 
concentrations with values ranging from 0,59 ± 0,17 mmol/L to 1,82 ± 0,77 mmol/L. Foals under 
24h of age tend to have higher plasma lactate concentrations which quickly normalize after 24h 
of age (Magdesian, 2004). Two studies demonstrated that postpartum foals had a concentration 
of 3,0 ± 0,4 mmol/L (Silver et al. 1987) and  found lactate levels for afterbirth, 12h and 24h old 
foals to be 4,9 ± 1,02 mmol/L, 2,25 ± 0,6 mmol/L and 0,89 mmol/L respectively (Kitchen & 
Rossdale, 1975). Attention should be payed when handling and restraining foals and adult 
horses since exercise, struggling and stress can cause temporary elevations in blood lactate 
levels (Magdesian, 2004). 
Some dogs and humans with lymphoma have been reported to be hyperlactemic or have 
hyperlactemia following LRS administration. Although such has not yet been reported for horses, 
neoplasia should be considered for horses with unexplained hyperlactemia (Allen & Holm, 2008; 
Magdesian, 2004).  
Normal values for adult horses are generally considered to be less than 1,5 mmol/L (Fielding & 
Magdesian, 2005; Nappert & Johnson, 2001) or 2,0 mmol/L (Magdesian, 2004). Two studies, 
mentioned by Magdesian (2004), performed in normal horses established normal blood lactate 
levels as 1,0 ± 0,3 mmol/L (0,7 – 1,7 mmol/L) and 1,04 ± 0.26 mmol/L (0,57 – 1,53 mmol/L).  
Plasma lactate concentrations can be considered as mild: 2,5 - 4,9 mmol/L; moderate: 5 - 9,9 
mmol/L; and severe: >10,0 mmol/L (Nappert & Johnson, 2001). While hyperlactemia is 
considered a mild increase in blood lactate concentration to 2 – 5 mmol/L, lactic acidosis is 
considered present when lactate concentrations in the blood rise above 5 mmol/L resulting in 
metabolic acidosis (Franklin & Peloso, 2006). Increases in plasma lactate have proved to have a 
strong correlation with the patient’s prognosis according to different authors in both human and 
veterinary medicine. 
In human medicine, intensive care physicians have concluded that changes in lactate 
concentration and lactate clearance during the first 24h provided the most information, prognosis 
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wise (Franklin & Peloso, 2006). Two studies demonstrated that early lactate normalization in the 
first 6 hours after resuscitation showed to have the strongest relation to survival of patients with 
sepsis or septic shock and that serial plasma lactate concentrations were more important than 
the lactate concentration at admission in predicting multiple organ failure and mortality in septic 
shock (Radcliffe et al., 2015). 
Several studies have been conducted to assess the relevance of lactate in sick dogs. One of 
these measured the lactate concentrations in 109 sick dogs and 20 healthy dogs concluding that 
95% of the animals in the sick group had plasma lactate concentrations higher than the normal 
reference values and higher than the median concentrations of the healthy dogs group. 25% of 
the sick dogs died or were euthanized and the median lactate concentration of these animals 
was higher than both the healthy and the sick survivor groups (Allen & Holm, 2008).  
A retrospective study on the relationship between gastric necrosis and plasma lactate 
concentration, obtained before treatment, in dogs with gastric dilation-volvulus concluded that 
gastric necrosis was present in 74% (23/31) of the dogs with lactate concentrations >6.0 mmol/L 
and only in 21% (15/71) of the dogs with < 6 mmol/L. Only 58% (18/31) of the dogs in the first 
group survived while 99% (69/71) of the dogs in the second group survived. Still in this study, 
gastric necrosis was present in 80% (16/20) of the dogs with lactate concentrations > 7 mmol/L, 
92% (11/12) of dogs with lactate concentrations > 8 mmol/L and 100% (7/7) of dogs with lactate 
concentrations > 10 mmol/L (Allen & Holm, 2008). 
Two studies done in dogs with babesiosis found plasma lactate concentrations to be a strong 
indicator of severity of illness, poor clinical presentation and prognosis, level of parasitemia and 
alterations in other blood biomarkers (Allen & Holm, 2008). 
In equine medicine, lactate measurements have proven to be of similar importance as in human 
medicine in assessing the patient’s condition and prognosis. Multiple studies have been done to 
clear the role of lactate measurements in equine critical care medicine. Equine colic is one of the 
main situations where lactate measurements may come in use. Less than 25% of the horses 
with colic that had plasma lactate concentrations greater than 11,2 mmol/L survived in 
comparison to 93% of horses with colic and lactate measurements ranging from 0,0 to 8,3 
mmol/L (Magdesian, 2004).  
The importance of serial lactate measurements as an estimation of prognosis is clear. A study 
by Johnston et al. (2007), on horses with a ≥ 360° large colon volvulus demonstrated that 
surviving horses had significantly lower plasma lactate concentrations at admission time than 
the non-surviving ones: 2,98 ± 2,53 mmol/L versus 9,48 ± 5,22 mmol/L respectively, and that the 
same happened for horses with a viable colon compared to nonviable colon: 3,3 ± 2,85 mmol/L 
versus 9,1 ± 6,09 mmol/L respectively. In the same study the authors also reported that the 
lactate levels 24h after surgery had returned to normal values of 0,96 ± 0,60 mmol/L in the 
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Figure 16: Algorithm for using blood lactate as a guide to fluid therapy (Fielding & Magdesian, 2005). 
horses that survived but remained significantly elevated for those who did not survive, with 
values of 3,24 ± 3,08 mmol/L. 
Another study on horses undergoing abdominal surgery showed that those with not only marked 
increases in plasma lactate before (> 7,5 mmol/L) but also with abnormal or increasing 
concentrations after surgery, had a guarded prognosis for survival (Radcliffe et al., 2015).  In the 
same way, Tennent-Brown et al. (2010), also showed that horses that died or were euthanized 
had a significantly higher lactate at admission than the surviving ones: 4 mmol/L (range 0,6-18,2 
mmol/L) versus 1,3 mmol/L (range 0,3 – 13,9 mmol/L), respectively. In the same study, large 
intestinal strangulating disease and colitis seemed to be have the strongest relation between 
elevated lactate and poor outcome. 
Although an evident relation between blood lactate concentrations and prognosis exists, some 
authors defend that special care should be taken when providing a diagnosis based solely on 
lactate values before treatment. The authors give the example of hypovolemic horses with colitis 
or hemorrhagic shock that present with considerable increases in lactate and respond well to 
aggressive fluid therapy, showing no relation between outcome and initial lactate values 
(Fielding & Magdesian, 2005). 
Curiously, in opposition to horses, ponies and miniature horses tend to have higher blood lactate 
concentrations at admission compared with horses but these haven’t proven useful in assessing 
the need for surgery, distinguishing strangulating from non-strangulating lesions and concluding 
about the risk of non-survival (Radcliffe et al., 2015).  
Although blood lactate concentrations may provide some information about the cause of colic, it 
is mainly an indicator of the general state of oxygen supply to tissues and oxygen consumption 
by anaerobic metabolism. Therefore, plasma lactate is mainly useful to estimate the severity and 
extent of shock as well as the response to therapy (Radcliffe et al., 2015).  
Plasma lactate concentrations at admission time and during the following hours/days have also 
shown to be strongly associated with prognosis in sick foals. Newborn foals with higher lactate 
concentrations usually have a story of dystocia or premature placental separation and/or are 
premature/dysmature foals. The most common diagnosis for foals with increased blood lactate 
are of sepsis, enterocolitis, enteritis, colic, trauma, respiratory disease, immune-related disease 
and encephalopathy (Radcliffe et al., 2015).Hyperlactemia and lactic acidosis should be treated 
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with large volumes of crystalloid replacement fluids. Fielding and Magdesian (2005) created an 
algorithm on how to use blood lactate concentrations as a guide for fluid therapy in adult horses 
(Figure 16).  
In cases of hyperlactemia due to hypoperfusion states, it is expected that, with adequate fluid 
therapy and volume resuscitation, the blood lactate concentrations will decrease fairly quickly. 
This algorithm was created mainly as an aid for field therapy and the authors insist that a 
detailed physical exam should be performed before initiating fluid therapy and that horses whose 
lactate concentrations keep increasing or did not reach values < 4 mmol/L after the third 20L 
fluid bolus may need additional laboratory evaluation and should be referred to a hospital. 
When hyperlactemia persists after fluids are administered, other causes such as severe 
inflammation, blood loss or sepsis should be considered (Radcliffe et al., 2015). Close attention 
should be payed to the presence of conditions responsible for increases in blood lactate but that 
do not beneficiate from the administration of large amounts of fluids such as heart failure or 
urinary obstructions (Fielding & Magdesian, 2005). 
Some may feel tempted to administer bicarbonate to lactic acidotic patients. Even though this 
will, in fact, correct the blood pH, it will not resolve the underlying cause of hyperlactemia and it 
might worsen the situation by causing a hypernatremic alkalosis on an already metabolically 
unbalanced patient (Smith, 2009). 
1.7. Creatinine and Urea 
Creatinine is a molecule resultant from the degradation of creatine and creatine-phosphate 
during muscle metabolism and excreted by the kidneys (Braun & Lefebvre, 2008; Radcliffe et al., 
2015). The skeletal muscle contains about 95% of the creatine and creatine-phosphate in the 
body although animals and humans can also obtain these molecules from meat in their diet 
(Braun & Lefebvre, 2008). Creatinine exists mainly as a free form in the plasma and is freely 
filtrated by the glomerulus but not reabsorbed in any part of the nephron, explaining why it 
represents a standard marker for estimating glomerular filtration rate and assessing kidney 
function (Braun & Lefebvre, 2008; Radcliffe et al., 2015). Although no kidney secretion of 
creatinine has been reported in cats or ponies, it is believed that creatinine is secreted by the 
renal tubules in horses and to a smaller scale in humans, rabbits, sheep and pigs (Braun & 
Lefebvre, 2008; Hollis & Corley, 2008). 
Even though plasma creatinine has been largely used to evaluate kidney function it is a weak 
marker for early loss of kidney function since it only rises after about 75% of the nephrons have 
lost their function (Radcliffe et al., 2015; Schott II, 2010). Still, a doubling of creatinine 
concentration is considered to correspond roughly to a 50% decrease of glomerular filtration rate 
(Schott II, 2010). Despite indicating a reduced glomerular filtration rate, serum creatinine levels 
alone are of little help when trying to understand the underlying cause for renal dysfunction 
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(Radcliffe et al., 2015). Never the less, plasma creatinine is a helpful tool to guide and monitor 
therapy and to estimate the prognosis, especially for critical care patients (Radcliffe et al., 2015). 
Normal serum creatinine concentrations for adult horses range from 0,9 to 1,9 mg/dL (Fielding, 
2015) or 2 mg/dL (Orsini & Divers, 2014) although it has been reported that normal adult Quarter 
horses and Warmbloods may have creatinine levels up to 2,4 mg/dL (Orsini & Divers, 2014; 
Radcliffe et al., 2015).  
Some newborn foals may have creatinine concentrations of 5 to 8 mg/dL and up to 13,6 mg/dL 
while maintaining a normal kidney function (Orsini & Divers, 2014; Radcliffe et al., 2015). These 
values have been related to foals born to mares with placental dysfunction, especially if blood 
urea nitrogen levels are normal , and with being bathed in amniotic fluid with abnormally high 
creatinine concentrations (Corley, 2008a; Schott II, 2010; Schaer & Orsini, 2014; Radcliffe et al., 
2015), and are expected to decrease to normal values within two to five days after birth in the 
absence of further complications (Corley, 2008a; Schott II, 2010; Schaer & Orsini, 2014). After 
the first days of life, the foal’s serum creatinine concentrations might be lower than the ones of 
an adult horse, probably due to their rapid growth and smaller proportion of skeletal muscle to 
body weight (Schott II, 2010). 
Renal hypoperfusion and nephrotoxic substances are the most common causes for acute kidney 
failure in horses and creatinine levels should be monitored whenever the patient’s in risk of one 
of these, as well as in situation where urinary tract obstruction or rupture is present or suspected 
(Radcliffe et al., 2015).  
Creatinine concentrations up to 3,5 mg/dL are common in moderately to severely dehydrated or 
hypovolemic horses (Cook & Bain, 2003; Corley, 2008a) but these values can reach 8 mg/dL in 
these animals (Radcliffe et al., 2015). However, high normal values ranging from 1,5 to 1,8 
mg/dL might be an indication of subclinical hypovolemia and should be taken into account along 
with clinical history, physical exam and other laboratory results (Corley, 2008a). 
Diarrhea and other gastrointestinal diseases, endotoxemia and septic shock, acute blood loss, 
hypovolemic shock, thrombotic episodes, coagulopathy, acute heart failure, and prolonged 
exercise are some of the most common causes  of vasomotor nephropathy (Schott II, 2010; 
Radcliffe et al., 2015). Increased creatinine values due to kidney hypoperfusion are expected to 
correct within a 36 hour period following correction of fluid deficits (Schaer & Orsini, 2014; 
Radcliffe et al., 2015). One should suspect actual kidney damage if creatinine levels do not 
decrease as expected with appropriate fluid administration (Corley, 2008a).  
Several authors agree that serial measurements of serum creatinine for patients in risk of 
developing acute kidney injury is of the utmost importance and that an increase of 0,3 mg/dL or 
greater in creatinine serum concentration, even if it remains within normal limits, is considered a 
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significant indicator for the developing of nephropathy (Divers, 2003b; Fielding, 2015; Radcliffe 
et al., 2015). 
Urea is the main form of nitrogen elimination in mammals. It is a small molecule synthetized in 
the liver from bicarbonate and ammonium and released into the sinusoidal blood as blood urea 
nitrogen (BUN) (Barton, 2010). Blood urea is freely filtered by the glomerulus and reabsorbed in 
the collecting tubule (Braun & Lefebvre, 2008). Urea reabsorption increases when urine flow 
within the tubule is reduced which may explain higher urea levels in dehydrated or hypovolemic 
animals (Braun & Lefebvre, 2008).  
Normal levels of blood urea nitrogen in adult horses range from 10 to 24 mg/dL according to 
Orsini and Divers (2014) or from 17 to 27 mg/dL according to Hollis (2008).  
Diet protein can represent a significant source of ammonium for the production of urea and low 
concentrations of blood urea nitrogen might be explained by low-protein diets or fasting (Braun & 
Lefebvre, 2008; Hollis & Corley, 2008). However, after a prolonged fasting, BUN levels rise, 
possibly due to body protein catabolism (Braun & Lefebvre, 2008). Schott II (2010) wrote that 
high-protein diets may cause a twofold or greater increase in BUN concentration and that there 
was a 50% or higher increase in blood urea after prolonged exercise in horses, possibly 
explained by a reduction in renal blood flow accompanied by an increase in protein catabolism. 
Conversely, Ainsworth (2002) affirms that increases in BUN in horses are rarely related to body 
protein catabolism or high-protein diets.  
Other explanation for low blood urea nitrogen concentrations is hepatic failure where the liver is 
incapable of converting ammonia into urea ( Durhan, 2008; Barton, 2010). Decreases in BUN 
due to liver failure are usually accompanied by increases in blood ammonia (Schott II, 2010). 
Although BUN concentrations have been found to be within normal limits in the majority of 
horses with hepatopathy, low BUN values in these animals usually relate to a poor prognosis 
(Durhan, 2008). Low BUN is also commonly found in young foals after situation of anabolic 
demand for aminoacids (Schott II, 2010) and in animals receiving anabolic steroids (Corley & 
Stephen, 2008).  
There are numerous reasons for increases in BUN and, besides the already mentioned 
increases from diet and protein catabolism. Causes related to kidney function are the most 
common ones (Hollis & Corley, 2008). Therefore, analyzing creatinine and BUN values 
simultaneously is of greater value when assessing kidney function. 
The term azotemia is used to describe the increase in blood creatinine and urea and it can be 
considered to be pre-renal, renal or post-renal whether the causes for such increments are due 
to decreased kidney perfusion, kidney disease or urinary tract damage or obstruction, 
respectively (Hollis & Corley, 2008; Schott II, 2010). A BUN/creatinine ratio greater than 15:1 
according to Divers (2003b) or greater than 20:1 according to Radcliffe et al. (2015) should be 
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indicative of pre-renal azotemia because of an increased urea reabsorption in cases of reduced 
urine flow in the proximal tubules. An increased BUN/creatinine ratio may also be indicative of 
post-renal azotemia due to urea absorption through the peritoneum in case of urinary tract 
rupture or due to reduced urine flow in obstructions (Radcliffe et al., 2015; Schott II, 2010). In 
some cases of acute renal failure secondary to diarrhea, blood urea nitrogen values may be 
normal or slightly elevated, due to protein loss, while creatinine values are greatly increased 
(Schaer & Orsini, 2014).  
In contrast, values inferior to 10:1 for the same ratio are more likely present in renal azotemia 
since the excretion of both molecules and the reabsorption of urea is impaired (Radcliffe et al., 
2015; Schott II, 2010).  
Some drugs administered to horses can result in serious nephrotoxic injury, especially in 
critically ill and dehydrated/hypovolemic patients whose kidney function might already be 
deranged. Aminoglycoside or tetracycline antimicrobials, NSAIDs and norepinephrine are some 
of the drugs commonly used in equine medicine that carry nephrotoxic properties ( Hollis & 
Corley, 2008; Schaer & Orsini, 2014; Radcliffe et al., 2015; Fielding, 2015b). Particular attention 
should be payed to NSAIDs that are often administered to horses suffering from gastrointestinal 
disease, sometimes as repeated doses, many times before proper evaluation of fluid balance 
(Hassel, 2015).  Polymyxin B can also exert nephrotoxic effects in its antimicrobial 
concentrations although when used in endotoxin-biding doses this risk is significantly reduced, 
yet not discarding the need for monitoring kidney function (Ainsworth, 2002; Hollis & Corley, 
2008; Schott II, 2010).  
Pigments like hemoglobin and particularly myoglobin may also be responsible for the onset of 
acute renal failure, particularly after tying-up or postanaesthetic myopathy episodes (Hollis & 
Corley, 2008; Schaer & Orsini, 2014). Other causes of acute renal failure include leptospirosis 
infections and intoxication with cantharadin from blister beetles, heavy metals, red maple or 
vitamin D (Hollis & Corley, 2008; Fielding, 2015b).  
In horses suffering from abdominal colic, higher blood concentrations of creatinine and urea 
proved to be related with increased mortality (Buchanan, 2014). A study involving 167 horses 
suffering from colic or colitis found that horses with azotemia that lasted longer than 72 hours 
had three times more chances of dying or being euthanized (Groover, Woolums, Cole, & LeRoy, 
2006). 
1.8. Total plasma proteins, total solids and albumin  
The plasma’s protein content has proved to be an important tool in assessing volemia status as 
long as pathologic protein losses or gains are excluded (Ethell, Dart, Rose, & Hodgson, 2000; 
Magdesian, 2015a). While total plasma proteins (TP) are measured by a chemistry analyzer, 
plasma’s total solids (TS) only require a refractometer making it easier, cheaper and faster to 
42	
	
measure, especially in field conditions (Magdesian, 2015). On the other hand, total solids 
measurements only represent the total protein concentration considering the remaining plasma 
components are within normal concentrations, for example, hyperlipidemia can cause an 
increase in total solids up to 2.0 g/dL (Weiser, 2012). The influence of serum glucose and urea 
concentrations in the measurement of total solids is negligible (Weiser, 2012).  
The three major constituents of plasma proteins are albumin, globulins and fibrinogen (Ethell et 
al., 2000).  
Albumin is synthesized in the liver and is the main protein responsible for maintaining the 
plasma’s oncotic pressure (Frandson, Wike, & Fails, 2009; Fielding, 2015). Many ions, 
hormones and drugs circulate binded to albumin, preventing their fast excretion through the 
glomerulus (Corley, 2008a; Frandson, Wike, et al., 2009). Albumin also works as a carrier of 
water-insoluble compounds in the plasma and, along with globulins and phosphate, is one of the 
main contributors for the buffer base in plasma (Corley, 2008aCorley, 2008aPalmer, 
2015)Palmer, 2015). 
Normal albumin concentrations for horses are  2,3 – 3,6 g/dL according to Corley & Stephen 
(2008) or 2,9 - 3,8 g/dL according to Orsini & Divers (2014).  Hyperalbuminemia in horses only 
seems to occur in severe dehydration (Corley & Stephen, 2008). Hypoalbuminemia may be due 
to chronic inflammatory disease, amyloidosis, tuberculosis, colitis, parasitism, starvation or other 
causes of protein loss mentioned below (Corley & Stephen, 2008; Mair, 2002a). Albumin 
concentrations inferior to 1 - 1,5 g/dL have been anecdotally considered the limit for edema 
formation in horses but there is still no scientific data to support these values (Fielding, 2015).  
Although hypovolemia causes the concentration of these proteins to increase more or less 
proportionally, there are other causes that may be responsible for the increase of just globulins 
or fibrinogen. Hyperglobulinemia may be present in response to chronic antigen stimulation or 
inflammation, for example in parasitism or closed-cavities infections like abdominal or thoracic 
abscesses (Corley & Stephen, 2008; Ethell et al., 2000), and hyperfibrinogemia is indicative of 
an active inflammatory or infectious disease (Corley & Stephen, 2008). 
Many common diseases in equine medicine result in protein depletion and, as mentioned 
before, the use of total plasma protein concentration is only reliable provided that there are no 
significant ongoing or recent protein losses (Ethell et al., 2000; Magdesian, 2015a). Causes for 
decreases in total plasma protein’s concentration, besides the mentioned above for 
hypoalbuminemia, are  GI ulceration, strangulating GI obstruction and protein-losing 
enteropathies, protein-losing nephropathy or glomerulonephritis, liver disease, acute blood loss 
and acute peritonitis or pleuritis (Ethell et al., 2000; Corley & Stephen, 2008; Hardy, 2010). 
Other causes for low plasma protein concentration that are not mandatorily related to morbid 
states include fluid overload, excess of water intake and severe malnutrition (Corley & Stephen, 
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2008; Hardy, 2010). Animals suffering from protein losses may, therefore, be dehydrated and 
still present normal plasma protein concentrations whereas the opposite may be observed in 
animals with increases in globulins and fibrinogen who are normovolemic (Ethell et al., 2000). 
Because protein levels in plasma are not altered by stress or excitement, as long as the 
conditions mentioned above are excluded, total plasma protein or total solids are often a better 
guide for extracellular fluid volume conditions than the hematocrit (Ethell et al., 2000).  
Normal plasma protein values for adult horses range from 5,2 to 7,2 g/dL according to Corley 
and Stephen (2008) or 5,5 to 7,5 g/dL according to Van Harraveld and Gaughan (2002). For 
foals normal plasma protein values go from 4,2 to 7,8 g/dL (Corley & Stephen, 2008).  
Orsini and Divers (2014) consider hypovolemia according to TP as mild for 7,0 - 8,0 g/dL, 
moderate for 8,0 - 9,0 g/dL and severe for TP values above 9 g/dL. Rose and Hodgson (2000) 
consider that horses with TP values under 7,5 g/dL don’t require fluid therapy while animals with 
TP values ranging from 7,5 to 8.5 g/dL have indication for IV fluids and horses with plasma 
protein concentrations greater than 8,5 g/dL definitely require intravenous fluids. 
Two studies experimenting the alterations of PCV and TP in horses deprived of water for three 
and eight days found that there were very little changes in PCV at the end of that period 
whereas TP levels increased significantly in both studies (Magdesian, 2015). 
Sequential measurements of plasma proteins provide the most reliable information about the 
patient’s evolution and therapy success (Corley & Stephen, 2008). 
Plasma protein concentrations of less than 4 g/dL have been considered the limit for edema 
formation in horses (Fielding, 2015).  
In horses with colic, plasma protein may be low due to sequestration into the abdominal cavity or 
intestinal lumen secondary to peritonitis or enteritis, respectively (Van Harraveld & Gaughan, 
2002). A study conducted by Parry et al. (1983), on individual variables used in case 
assessment as a way to define prognosis in colic cases, did not find significant differences 
between the total plasma proteins of the surviving and nonsurviving groups, however, the 
authors explain that all horses with less than 5,2 g/dL total proteins at admission died.  
Mair and Smith (2005) studied the association between several baseline variables at admission 
and the development of post-operative shock in 252 horses undergoing colic surgery. The 
authors found that 36,8% of the horses with TP greater than 9 g/dL developed post-operative 
shock, while the same only happened for 13,3%, 15,6%, 7,0% and 16,7% of the horses with TP 
of 8–8,9 g/dL, 7–7,9 g/dL, 6–6,9 g/dL and < 6 g/dL, respectively. 
1.9. Packet cell volume 
 Packed cell volume (PCV) or hematocrit represents the portion of blood composed by 
erythrocytes (Weiser, 2012). PCV can easily be measured using the microhematocrit technic, 
considered to be the most accurate technic by Tennent-Brown (2015), or using an automatic cell 
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count machine (Sellon, 2010; Weiser, 2012). As what happens for total plasma protein or total 
solids, measurement of PCV is one of the most frequently conducted tests in equine practice 
and can be useful in assessing hydration status at admission and help monitor therapy through 
sequential measurements (Corley, 2008a; Ethell et al., 2000). The biggest downfall of PCV is 
that it can be affected by splenic contractions in response to stress or excitement or in the 
presence of real polycythemia ((Rose & Hodgson, 2000; Sellon, 2004Corley, 2008; Nolen-
Waltson et al., 2011; ).  
There also seems to exist a considerable variation in PCV among different types (Table 4) and 
breeds of horses as well as among animals of the same breed (Sellon, 2010; Tennent-Brown, 
2015). For example, a review of anemia in horses showed Thoroughbred horses to have a 
normal PCV of 41% ± 3,8 while Clydesdales had a PCV of 33% ± 3 (Sellon, 2010).  
Table 4: PCV values according to type of horse. Adapted from Sellon (2010). 
              Light horse Draft horse Miniature horse 
PCV (%) 32-50 24-44 24-42 
 
There are several reasons for PCV to decrease, resulting in anemia. These may be classified 
into regenerative anemias such as the ones caused by hemorrhage and hemolysis or classified 
as nonregenerative anemias like the ones secondary to iron deficiency, chronic inflammation, 
neoplasia, endocrine diseases and generalized bone marrow failure (Sellon, 2010), besides 
iatrogenic fluid overload (Fielding, 2015). One must be aware that the presence of anemia 
simultaneously to hypovolemia may originate a falsely low or normal PCV (Sellon, 2010). 
Pathologic rises in PCV happen in cases of acute blood loss and hypovolemia (Sellon, 2010). A 
PCV greater than 45% usually reflects contraction of the plasma volume (Ethell et al., 2000) and 
non-exercising horses with hematocrits above 50% are almost always hypovolemic (Corley, 
2008a), although Orsini and Divers (2014) consider the normal PCV values for adult horses to 
range from 32% to 53%. Some authors doubt the sensitivity of PCV as a hydration status 
indicator. Two studies that deprived horses from water for three and eight days showed no 
significant changes in PCV at the end of that period whereas TP levels increased significantly in 
both studies (Magdesian, 2015).  
Van Harraveld and Gaughan (2002) link a PCV greater than 65% to a poor prognosis in horses 
with colic.  Proudman, Smith, Edwards, & French (2002b) compared the PCV between horses 
surviving colic surgery and those dying or being euthanized prior to recovering from anesthesia, 
and concluded that baseline PCV for the surviving group was of 38 ± 8% whereas for the 
nonsurviving group was of 50 ± 11%. A study conducted by Ihler, Venger, and Skjerve (2004) 
found that, for horse’s that were treated medically for colic, the surviving group had a mean PCV 
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of 34%, ranging from 22 to 50%, while the nonsurviving group presented a mean PCV of 48%, 
ranging from 33 to 69%.  
Mair and Smith (2005) studied the association between several baseline variables at admission 
and the development of post-operative shock in 252 horses undergoing colic surgery. The 
authors found that 52,4% of the horses with a PCV greater than 50% developed post-operative 
shock, while the same only happened for 14,3%, 8,9% and 5,4% of the horses with PCV of 40-
49%, 30-39% and < 30%, respectively. 
A study by Proudman, Edwards, Barnes, and French (2005) analyzing 275 horses undergoing 
surgery for large intestinal disease found PCV values on admission to be significantly and 
positively related to post-surgery mortality. Later, Proudman et al. (2006) analyzed 774 equine 
surgical colic cases and confirmed that there was a strong relation between PCV at admission 
and intra or post-surgery mortality but this was not a linear relation. The authors explain the 
existence of an “optimum” PCV interval and the further the horse’s values are from this interval, 
the worse the prognosis for survival. Another study looked at the association of capillary refill 
time, PCV and pain with mortality in 152 horses and found that the mortality rate was higher 
(69%) in horses with a PCV greater than 54%, although these were not statistically significant 







The present work is a preliminary study that aims to determine the existence of a beneficial 
effect in administrating a 2 litter bolus of 7,2% hypertonic saline solution, as a part of medical 
treatment, to horses suffering from gastrointestinal colic, admitted to the Brazos Valley Equine 
Hospital, Navasota. Several circulatory and blood parameters were measured in an attempt to 
determine the effects of the administration of a bolus of HSS in comparison to the control group 
receiving a bolus of LRS. This study intends to reflect a practical approach to medical treatment 
of equine colic as seen on the day to day practice. 
2.2. Materials and methods  
2.2.1. Case enrolment criteria  
Three criteria were set for a horse to enroll this study: suffer from gastrointestinal colic, be in 
need of IV fluid therapy and weight between 400 and 500 Kg. 
Horses presenting with complaints of abdominal pain were assessed by one of the practitioners 
working at the hospital. A full physical exam was performed by the practitioner with help from 
one of the interns. Physical exam consisted of recording heart rate, capillary refill time, mucous 
membrane’s color and moisture, jugular vein filling and rectal temperature. All horses were also 
subjected to an abdominal ultrasound, rectal palpation and to the passing of a nasogastric tube 
to confirm the presence of gastric reflux. Laboratory tests such as PCV, TS and plasma lactate 
were performed for all cases and more complete laboratory tests were also conducted if the 
practitioner decided so. 
For some cases, the cause of colic was diagnosed after physical exam while for the rest it 
remained unknown. Horses for whom an exact diagnosis was not possible, but the possibility of 
a false colic was excluded, were considered to suffer from gastrointestinal colic.  
Horses suffering from GI colic and that were in need of IV fluid therapy were admitted to the 
study. No criteria was defined for deciding if a horse should receive IV fluid therapy. The 
decision of administrating IV fluids relied solely on the practitioner in charge of the case, and it 
was based on the physical exam, lab results and cause of colic as happens on the day to day 
practice.  
Since this study was intended to reflect a practical approach to the medical treatment of colics, it 
was defined that all horses enrolling in this trial were to receive a 2L bolus of fluid, as it is the 
common practice at BVEH for adult horses with colic to receive a fixed dose of 2L of hypertonic 
saline solution before receiving intravenous isotonic fluids. The initial criteria was for horses to 
weight between 400 and 500 Kg, which would correspond to a dose of 5 to 4 ml/Kg of HSS per 
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Figure 17: Blinding 
method: 1L bottle of 
fluid with the label 
taped and the letter B 
written on it. 
horse. However, due to the low caseload, three horses weighing slightly more than 500 Kg were 
admitted into the trial. 
2.2.2. Blinding method 
Both bottles of Lactated Ringer’s Solution and Hypertonic Saline Solution 
were identical except for their label. The technician responsible for the 
hospital’s pharmacy was asked to tape the labels of the bottles of both 
solutions, writing only “A” and “B” on each type (Figure 17). For the entire 
trial this technician was the only one to know which letter matched which 
fluid. A set of taped bottles was kept in the pharmacy, separated from the 
rest of the fluids, at all times, to avoid any kind of confusion.  
2.2.3. Randomizing method 
Horses were randomized as to which type of fluid bolus they should receive. 
Horses were grouped two by two and a coin was tossed for the first one of each group. To 
heads corresponded fluid A and tails matched fluid B. The second horse of the group would 
receive the type of fluid the first one didn’t, allowing us to have a similar number of horses 
receiving boluses of HSS and control horses receiving LRS (HSS group and LRS group, 
respectively). Even though the horses enrolling this study were never admitted into the hospital 
at the same time, a tight record of the all the enrolled cases was kept, informing us to toss the 
coin or administer certain fluid to the horse being worked on at the time.  
2.2.4. Administered drugs 
All horses received a dose of flunixin meglumine calculated for their weight before being 
enrolled in the study. Three horses required sedation to facilitate handling and examination as 
well as a safety measure for the horse and staff. The administered sedation was of 200mg 
xylazine IV for each horse, which represented a dose of 0.40-0.44 mg/Kg. No effects of 
excessive sedation were noticed in any of the horses.  
2.2.5. Parameter measurements 
After a horse was enrolled in the study, a number of parameters were evaluated before, 
immediately after and 90 minutes (T0, T1 and T2, respectively) after the administration of the 
fluid bolus. These parameters consisted in measuring central venous pressure and non-invasive 
blood pressure as well as PCV, TS, plasma lactate and whole blood lactate, plasma 
biochemistry profile, and blood pH. All parameters were recorded on a data sheet created for 
each horse (Appendix 2). Due to the limitations concerning the length of this dissertation, a 
selection of the most relevant parameters for analysis and discussion was made. All blood 
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collection and sample handling operations, iSTAT® use and CVP and NIBP measurements were 
performed by the same person. 
 
 
2.2.5.1 Administered fluids 
As explained before, horses were randomized in groups receiving a 2L bolus of Vet One® 7,2% 
hypertonic saline solution and a control group that received a 2L bolus of Vet One® Lactated 
Ringer’s Solution. As soon as all the necessary parameters for T0 were collected, the fluid 
boluses were administered to all horses through a 14 gauge IV catheter, placed in the jugular 
vein. After collecting the parameters for T1, all horses were put in a stall where, until T2, they 
received 10 litters of Plasma - Lyte A (Abbott Laboratories, North Chicago, IL) through their IV 
catheter. Horses were not allowed to drink water for the duration of the study. The composition 
of these fluids is described in Table 2 on chapter 1.2. After collection of the T2 parameters, all 
horses proceeded to receive the amount and type of fluids the responsible practitioner thought 
adequate.  
Although commercial lactate analyzers are not supposed to detect the lactate present in the 
LRS, we noticed that the lactate analyzer used in this study detected a lactate concentration of 
5,2mmol/L in the Vet One® Lactated Ringer’s Solution used for the control group. These results 
will be presented and discussed later. 
2.2.5.2. Central venous pressure and measurements 
Central venous pressure was measured following the method described by Fielding et al. 
(2004). A sterile 1,2 mm x 56 cm, French Sovereign™ 
polypropylene catheter, filled with heparinized fluid, was 
inserted through a 14 gauge intravenous catheter previously 
placed on the jugular vein. Roughly one 
centimeter of the tip of the polypropylene 
catheter was cut off, previous to its 
insertion, in order to eliminate the blunt 
end and lateral openings. The catheter 
was then attached to an electronic pressure transducer connected to a 
Mindray™ PM-9000Vet monitor (Figure 18). The electronic pressure 
transducer was leveled with the point of the horse’s shoulder tip and taped 
to it in order to maintain the same “zero” mark for all measurements, as 
described on chapter 1.6. Between T0 and T1 the pressure transducer was 
Figure 19: Pressure 
transducer taped to 
the horse’s shoulder 
tip and a 20 mL 
syringe filled with 
heparinized fluid 
attached to the 
transducer. The 
bottom piece of tape 
was kept in the same 
place throughout all 
operations to avoid 
variations of the 
“zero” level. 
Figure 18: Mindray™ PM-9000Vet 




Figure 20: Mare in stocks while CVP and NIBP are being 
measured. Notice how she is minimally restrained and maintains 
her head in a nearly neutral position. 
kept attached to the horse. Between T1 and T2, since the horse would not stay in the stocks, the 
line of white tape attaching the pressure transducer was left in the horse’s shoulder. A 20 mL 
syringe filled with heparinized fluid was kept attached to the pressure transducer and the entire 
line was flushed before and in between each CVP measurement (Figure 19).  
Noninvasive arterial blood pressure was measured using the oscillometric sphygmomanometry 
method as described in chapter 1.7. by placing an inflatable cuff around the coccygeal artery on 
the base of the tail. The cuff was attached to the same monitor used for the CVP readings, 
which displayed both parameters simultaneously, and the horse was allowed to get used to the 
cuff inflation and deflation before NIBP values started being recorded. NIBP values were used 
as uncorrected values and the bladder 
width to tail girth ratio was not 
calculated, being that the hospital 
features a set of different sized 
inflatable cuffs. 
The horses were kept in stocks for all 
operations and efforts were made for 
the horse’s head to stay in a neutral 
position with minimal restraining and 
for the animal to be relaxed and quiet 
(Figure 20). If the horse’s behavior or 
position changed greatly the correspondent reading would be excluded. Three measurements 
were recorded for each parameter at each time point and the used value was the mean of these. 
2.2.5.3. Packed cell volume, total solids, plasma lactate and plasma biochemistry  
Blood was collected from the jugular vein of the side opposite to where the intravenous catheter 
was placed using a sterile 18 gauge needle and a 5 mL syringe. Immediately after collection, 
the blood was transferred into a plain blood tube under vacuum (red top) and a blood tube 
containing lithium heparin under vacuum (green top). The green top tube was then centrifuged 
for three minutes.  
PCV was measured by filling two microhematocrit tubes and centrifuging them for three 
minutes. The PCV value was considered to be the mean of the two microhematocrit results 
unless there was a clear disparity among these in which case the technic would be repeated.  
TS and plasma lactate were measured using plasma obtained from the centrifuged green top 
tube. TS were measured using a refractometer and plasma lactate was measured using a 
commercial point-of-care Nova Biomedical Lactate Plus® analyzer. This analyzer was found to 
have the lowest intra-analyzer variability and showed the best agreement to a bench top 
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analyzer, in blood of horses with colic, when compared to two other portable lactate analyzers 
(Nieto, Dechant, le Jeune, & Snyder, 2015).  
A plasma biochemistry panel was analyzed using the bench top analyzer HESKA™ DRI-CHEM 
7000. Although a full biochemistry panel was ran for each horse and each time point, we chose 
to present and discuss solely the values for albumin, blood urea nitrogen, creatinine, and total 
plasma protein due to their relation to prognosis in equine colic.  
2.2.5.4. Venous blood pH and whole blood lactate 
Blood pH and lactate was assessed using the commercial analyzer VetScan® iSTAT®1 and a 
CG4+ cartridge. The sample of blood used was collected into a blood tube under vacuum 
containing lithium heparin, as explained previously, but not centrifuged. Efforts were made to 
minimize the time between collecting the blood and placing the sample on the CG4+ cartridge. 
A new sterile syringe was used to transfer the blood sample from the blood tube to the cartridge 
and the first drops from the syringe were discarded. Even though the CG4+ cartridge provides 
information about blood gases and several other parameters, it was decided that blood pH and 
lactate would be the most relevant variables to discuss in this dissertation. 
2.3. Statistical analysis 
A descriptive statistics of our data was performed using the Rcmdr Version 2.3-0 software. Due 




2.4. Results and discussion 
A complete table of the obtained results is presented in the appendix section (Appendix 1). 
2.4.1 Enrolled animals 
Eight horses were admitted to this study resulting in an even distribution of four horses for the 
HSS group and for the LRS group. The description of the enrolled animals is presented on table 
5. 
Table 5: Baseline characteristics of horses enrolled in this study receiving a 2L bolus of  
7,2%  hypertonic saline solution (HSS) or Lactated Ringer's Solution (LRS) (mean ± sd) 
 HSS LRS 
N 4 4 
Age (years) 11,25 ± 7,89 10,50 ± 3,87 
Weight (Kg) 481,00 ± 38,50 483,75 ± 23,75 
Breed 
3 Quarter Horses 
1 Gypsy Vanner 









1 Large colon 
displacement 
1 Ileal impaction 
1Colon impaction 
1 Unknown 
1 Large colon 
displacement 
1 Ileal impaction 
2 Unknown 
 
2.4.2. Central venous pressure 
CVP values for HSS and LRS groups at T0, T1 
and T2 are represented in Graphic 1. CVP values 
for each horse at all time points are displayed on 
table 6. 
Group Horse T0 T1 T2 
Graphic 1: CVP values for HSS and LRS groups at T0, 




Baseline CVP values were of 10,5 ± 7,72 cmH₂O for the HSS group 
and of 9,5 ± 9,75 cmH₂O for the LRS group, representing a high 
variability of these parameter’s values among horses of both 
groups. Although both group’s mean CVP increased after the 
administration of the fluid bolus, the LRS group’s mean CVP 
increased less than 2 cmH₂O while the HSS group’s increased in 
more than 4 cmH₂O. After 90 minutes (T2) the HSS’s mean was lower than at T1 while the 
LRS’s mean kept increasing. At T2 both group’s means had converted to similar values at 12,75 
± 3,30 cmH₂O and 13,75 ± 8,66 cmH₂O for the HSS and LRS groups, respectively.  
On the HSS group one of the horses (Horse 1 on Table 5) had a slight drop in CVP after 
receiving the fluid bolus while all other horses had visible increases. At first this was thought to 
be due to the peripheral vasodilation and consequent 
temporary hypotension as explained by Kien et al. (1998), 
Kreimeier & Messmer (2002) and Oliveira et al. (2002). However, this hypotensive period is 
usually shorter than the observed with this horse which lead us to believe the possibility of a 
technical error having happened in T0 that caused a falsely high CVP value, such as a kinked 
catheter tip, air within the lines or some kind of catheter obstruction (Fielding et al., 2004; 
Magdesian, 2004).  
There was one mare on the LRS group (Horse 7 on Table 5) whose T0 CVP value was of 24 
cmH₂O and had risen to 26 cmH₂O at T1 and T2. The diagnose was a displaced large colon 
and the mare was presented with a distended left flank, being that the abnormally high CVP was 
attributed to the increase in intraabdominal pressure (Gelman, 2008; Magdesian, 2004). 
However, less than 24 hours later, the mare was no longer distended or painful but the CVP 
remained equally elevated. No cardiac, pulmonary or other kind of cause was found to justify 
these values 
Never the less, and even though the number of horses was too low to allow us to conclude 
about any kind of significance, the behavior of the values observed on the graphic matches the 
expected, as the plasma expansion and increased cardiac function caused by the administration 
of a hypertonic solution will lead to an increase in intravascular volume and, therefore, of the 
central venous pressure (Schmall, 1989; Schmall et al., 1990; Pantaleon, 2005; Taylor & Clark, 
2007; Robertson, 2010; Theobaldo et al., 2012; Magdesian, 2015b). However this effect is of 
short duration, explaining the lower values at T2 compared to T1 for the HSS group. The values 
for the LRS group also behave as expected since all horses received a 10L bolus of isotonic 
solution between T1 and T2, explaining the improvement in this group’s CVP mean. 
Although baseline CVP measurements may prove to be useful, especially in the presence of 
extreme values, a lot of patients may be under serious hemodynamic derangements and still 
HSS 
1 19 14 13 
2 3 9 9 
3 15 23 17 
4 5 13 12 
LRS 
5 3 5 6 
6 5 6 13 
7 24 26 26 
8 6 7 10 
Table 6:  CVP (cmH₂O) values for each 
horse at each time point. 
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have a central venous pressure within normal limits. This is due to the body’s responses towards 
maintaining homeostasis, which enhances the importance of performing continuous or serial 
CVP measurements as a way to monitor the therapy’s effects and the patient’s condition 
(Gelman, 2008; Magdesian, 2015b). All horses, except for Horse 1 mentioned above, had higher 
CVP values at T2 than at admission (T0). This fact lead us to believe that even the animals who 
presented baseline CVP values considered within normal range were probably in need for some 
kind of fluid replacement.  
2.4.3. Noninvasive blood pressure 
Mean arterial pressure values for the HSS 
and LRS groups at each time point are 
represented on Graphic 2. MAP values for 
each horse at each time point are presented 
on Table 7. 
 
As explained on chapter 1.7, a minimal MAP of 50 to 60 mm Hg is fundamental for an adequate 
organ perfusion and it’s this value, more than systolic and diastolic arterial pressures that 
secures perfusion in the critically ill patient (Magdesian, 2004).  
Even though the mean baseline of the HSS group (71 ± 17,98) was considerably lower than the 
LRS group’s (91 ± 12,36), at T1 it had risen to values above the LRS ones, returning to lower 
values, but still higher than at T0, at T2. The mean MAP for the LRS group decreased slightly at 
T1 but after 90 minutes it showed some improvements as expected after the administration of 
10L of Plasma – Lyte A.  
Only one horse of each group (Horse 4 and 7 on Table 7) had lower MAP values at T2 than at 
T0. Although the decrease in MAP for Horse 7 doesn’t seem to be relevant, the decrease in 
Graphic 2: Noninvasive MAP mean ± SE for HSS and 
LRS groups at T0, T1 and T2. 
Table 7: MAP values (mmHg) for each 
horse at each time points. 
Group Horse T0 T1 T2 
HSS 
1 70 89 82 
2 49 123 112 
3 93 98 108 
4 72 87 61 
LRS 
5 79 88 78 
6 86 95 111 
7 91 84 88 




MAP for Horse 4 may be attributed to a higher stress and/or pain level at T0, to the worsening of 
the patient’s circulatory status despite the administered fluids or other possibilities described on 
chapter 1.7 such as the onset of endotoxemia or acid-base derangements (Gay et al., 1977).  
Horse 2 on Table 7 exemplifies a good situation where a horse benefits from the administration 
of HSS. This horse was clearly hypovolemic (see also Table 6, Horse 2) and the administration 
of a HSS bolus secured appropriate central venous pressure and mean arterial pressure until a 
larger volume of isotonic fluids was administered. 
 
Gay et al. (1977) showed how low systolic blood pressure was associated to a poor prognosis in 
horses undergoing colic surgery and later, Parry, Anderson, and Gay (1983), corroborated the 
same by reporting how low systolic and diastolic arterial pressures were related to mortality in 
horses with colic.  
In our study, mean systolic and diastolic arterial pressures behaved in a similar pattern as MAP 
for both groups as can be observed on Graphics 3 and 4. Once more the HSS group’s values 
behaved as expected, increasing after the HSS bolus caused a plasma expansion and 
improved the cardiac function, and decreasing at T2 due to the short duration of the HSS effects 
but still maintaining the effects of the 10L bolus and maybe even some remaining effects of the 
hypertonic solution.  
The decreases of all three parameter’s mean between T0 and T1 for the LRS group may be 
explained by one horse (Horse 8 on Table 7) whose MAP, systolic and diastolic arterial 
pressures decreased abruptly between T0 and T1, impacting the group’s means. This decrease 
was attributed to the reduction of the initial stress as the horse overcame stressful stimulus like 
transport, handling and physical exam.   
Graphic 3 and Graphic 4: noninvasive systolic (SYS.NIBP) and diastolic (DIS.NIBP) arterial pressures mean 




Errors concerning technic execution are also a possibility that can’t be overlooked. Even though 
the bladder width to tail girth ratio was not calculated, the same inflatable cuff was used for each 
horse across all time points and, since the hospital owns a set of different sized cuffs, it was 
possible to select the most appropriate one for each horse. There was no correction of the 
obtained results but the goal of this study was to observe the variations of arterial blood 
pressure at different time points rather than its exact values. 
2.4.4. Packed cell volume 
Mean PCV values for both groups at each time 
point are represented on Graphic 5. PCV values 
for each horse at each time point are presented 
on Table 8. 
Mean baseline PCV values were similar for both 
groups (45 ± 8,72 % for the HSS group and 
45,25 ± 4,57% for the LRS group), yet the mean 
hematocrit for the HSS group suffered a bigger  
drop 
from T0 to T1 than the LRS group’s one.  
Even though the size of the sample is too small to 
allow us to calculate the existence of a significant 
difference between both groups, by observing Table 
8 it’s possible to conclude that the drop in PCV, 
between T0 and T1, for the HSS group ranged from 
8 to 16%, with a mean drop of 13,5%, while for the LRS group it was of 0 to 6%, with a mean 
4,5%. Even at T2, after all horses received a 10L bolus of isotonic fluids, the drop in PCV, 
compared to baseline, for the HSS group ranged from 6 to 14%, with a mean of 11%, while for 
the LRS group it went from 3 to 10%, with a mean drop of 6,75%. A bigger drop in PCV in the 
HSS group compared to the LRS group is consistent with previous studies conducted in this field 
(Schmall et al., 1990; Bertone & Shoemaker, 1992; Fielding & Magdesian, 2011). 
The hematocrit may be pathologically elevated in situations of acute blood loss or hypovolemia 
(Corley, 2008a; Ethell et al., 2000; Nolen-Waltson et al., 2011; Fielding & Magdesian, 2015). 
Knowing that a PCV greater than 45% usually means there’s some contraction of the plasma 
volume (Ethell et al., 2000) and that hematocrits above 50% are almost always present in 
Graphic 5: PCV mean ± SE for HSS and LRS 
groups at T0, T1 and T2. 
Table 8: PCV values (%) for each horse at 
each time points. 
Group Horse T0 T1 T2 
HSS 
1 50 36 36 
2 48 32 36 
3 32 24 26 
4 50 34 38 
LRS 
5 43 43 40 
6 50 44 44 
7 40 34 32 




hypovolemic horses (Corley, 2008a), we can conclude that at least five of the enrolled horses 
had some degree of plasma volume deficit. 
However, PCV values are extremely variable among breeds and even among individuals within 
the same breed. Horse 3 was a Gypsy Vanner, a breed of draft horse. According to Sellon 
(2010), PCV values for draft horses range from 24 to 44%, meaning that, even though this 
horse’s hematocrit seemed normal at first, it could, in fact, be elevated for that individual.  
Besides differences among individuals, PCV can be physiologically elevated by splenic 
contractions in response to stress or excitement ((Rose & Hodgson, 2000; Sellon, 2004; Corley, 
2008a; Nolen-Waltson et al., 2011)￼. Horses from our study were painful, submitted to, 
sometimes long, trailer rides and to relatively invasive physical exams (rectal exam, nasogastric 
intubation, etc.) which could all contribute for splenic contraction and increases in PCV. 
All the factors capable of influencing the PCV decrease this test’s liability, especially when used 
individually. Ideally, PCV should be interpreted along with total solids or total plasma protein, at 




2.4.5. Total solids, total protein and albumin 
Mean total solids and total plasma protein 
values for both groups at each time point are 
represented on Graphics 6 and 7, respectively.  
The concentrations of TS are similar to the 
concentration of  TP at all time points which 
indicates us that there was little or no 
interference of the remaining plasma 
components with the refractometer’s reading 
(Weiser, 2012). However, for one horse of each 
group the TP at T0 were 0,5 g/dL lower than the 
TS and for one horse of the LRS group the 
baseline TP was 0,9 g/dL lower than the TS. 
These differences are hard to explain being that 
they could be due to technical errors or the 
presence of plasma constituents that affected 
the refractometer’s reading. 
At T1 and T2 the maximum difference between 
TS and TP was of 0,4 g/dL. 
The concentration of plasma protein is an 
important tool in assessing volemia status as 
long as ongoing or recent protein losses are 
excluded (Ethell et al., 2000; Magdesian, 
2015a). None of the horses enrolled in our 
study presented, or developed in the following 
24 hours, any signs of protein losses like 
diarrhea or nephropathy, leading us to consider 
the obtained TS and TP as reliable 
hypovolemia indicators. 
Orsini and Divers (2014) consider hypovolemia according to TP as mild for 7 - 8 g/dL, moderate 
for 8 - 9 g/dL and severe for TP values above 9 g/dL. Rose and Hodgson (2000) consider that 
horses with TP values under 7,5 g/dL don’t require fluid therapy while animals with TP values 
ranging from 7,5 to 8,5 g/dL have indication for IV fluids and horses with plasma protein 
concentrations greater than 8,5 g/dL definitely require intravenous fluids. 
Mean baseline TP for the HSS and LRS groups were 7,53 ± 0,82 g/dL and 7,0 ± 0,5 g/dL, 
respectively, and only one horse of each group had a TP concentration inferior to 7 g/dL.  
Graphic 7: Total plasma protein mean ± SE for both 
HSS and LRS groups at T0, T1 and T2. 
Graphic 6: Total plasma solids mean ± SE for HSS 




Graphic 8 represents the mean Albumin values for 
both groups at all time points. As described above 
none of the enrolled horses presented, or developed 
in the following 24 hour period, signs that indicated 
possible albumin losses.  
Normal albumin concentrations for horses range 
from  2,3 to 3,8 g/dL (Corley & Stephen, 2008; 
Orsini & Divers, 2014). Hyperalbuminemia in horses 
only seems to occur in severe dehydration (Corley & 
Stephen, 2008) and none of the horses of our study 
presented albumin concentrations out of the normal 
range.  
Even though the study’s sample is too small to allow us to calculate the presence of significant 
differences between groups, by observing the Graphics 6, 7 and 8 it’s possible to notice that the 
drop in TS, TP and Albumin between T0 and T1 is greater for the HSS group than for the LRS 
group. This decrease  in TP is consistent with previous studies conducted in this field (Schmall 
et al., 1990; Bertone & Shoemaker, 1992; Fielding & Magdesian, 2011). Between T1 and T2, 
total protein, total solids and albumin values for the HSS group increased as the effects of the 
hypertonic saline solution bolus wear off, however they remained inferior to T0 as the 10L bolus 
of isotonic fluids maintained some of the plasma volume expansion. The LRS group’s values for 
the same variables decreased along the two time intervals (T0-T1 and T1-T2) as 2 and 10 litters 
of isotonic fluids were added to the plasma volume. 
Plasma protein concentrations of less than 4 g/dL and albumin concentrations inferior to 1 - 1,5 
g/dL can be considered as the limit for edema formation in horses (C. L. Fielding, 2015). None of 
the horses presented, at any time point, TP or albumin values inferior to these, which lead us to 
believe that there was no need to add or replace the crystalloid fluids by synthetic or natural 
colloids. 
  
Graphic 8: Albumin mean ± SE for the HSS and 
LRS groups at T0, T1 and T2. 
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2.4.6. Creatinine and BUN 
Mean creatinine and BUN values for both 
groups at each time point are represented 
on Graphics 9 and 10 respectively.  
Mean baseline creatinine for the HSS and 
LRS groups were 2,02 ± 0,33 mg/dL and 
1,45 ± 0,52 mg/dL, respectively. 
Normal serum creatinine concentrations for 
adult horses range from 0,9 to 2 mg/dL 
(Orsini & Divers, 2014; Fielding, 2015b) 
although it has been reported that normal 
adult Quarter horses and Warmbloods may 
have creatinine levels up to 2,4 mg/dL 
(Orsini & Divers, 2014; Radcliffe et al., 
2015).  
Even though all of the horses of our study 
had creatinine concentrations within the 
normal range, high normal values could 
indicate the presence of subclinical 
hypovolemia (Corley, 2008a). 
Normal levels of blood urea nitrogen in 
adult horses range from 10 to 27 mg/dL 
according to Hollis (2008) and Orsini and 
Divers (2014) 
Mean baseline BUN values for the HSS and 
LRS groups were 19,95 ± 7,35 mg/dL and 
19,85 ± 3,67 mg/dL, respectively. 
Gastrointestinal diseases are one of the most common causes for kidney injury due to 
hypoperfusion (Radcliffe et al., 2015; Schott II, 2010) and, in horses suffering from abdominal 
colic, higher blood concentrations of creatinine and urea proved to be related with increased 
mortality (Buchanan, 2014). 
Creatinine concentrations for the LRS group remained approximately the same between T0 and 
T1 and decreased slightly at T2. 
In our study, the HSS group showed a slight reduction in creatinine levels at T1, however, the 
same did not happen for the BUN levels, which remained practically the same after the 2L bolus 
of HSS.  
Graphic 9: Creatinine mean ± SE for the HSS and LRS 
groups at T0, T1 and T2. 
Graphic 10: BUN mean ± SE for the HSS and LRS 
groups at T0, T1 and T2. 
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In opposition to what happened with the previous blood parameters, there is a slight increase in 
BUN after the administration of the two litter bolus of lactated Ringer’s solution. No relation 
between the administration of LRS and increases in urea production was found, however, it has 
been proposed that increased oxygenation of liver tissue promoted the production of urea 
whereas liver hypoxia reduced this molecule’s synthesis (Opie, 1960, 1961). Even though the 
administered volume of LRS was of only two litters, it is possible that this amount of fluids was 
enough to increase liver perfusion and urea production. The administration of HSS was also 
likely to increase liver perfusion and, consequently, cause an increase in total BUN, 
nevertheless, because of the simultaneous plasma expansion, BUN concentration at T1 
remained similar to T0.  
At T2, BUN concentrations decreased slightly in both groups, most likely due to the dilutional 
effect of the 10L bolus of Plasma - Lyte A as well as increased renal excretion. 
The administration of hypertonic saline solution showed to increase blood flow to the kidneys 
(Schmall, 1989; Kien et al., 1998). The improved kidney perfusion and higher plasma sodium 
concentration after HSS administration result in a shorter time to urination, increased urinary 
frequency and more diluted urine, which is believed to act as a protective effect against renal 




2.4.7. Plasma lactate and blood lactate 
Mean plasma and whole blood lactate values 
for both groups at each time point are 
represented on Graphics 11 and 12, 
respectively.   
Both lactate values were obtained using two 
different commercial analyzers as explained 
on chapter 2.2.5.4. Whole blood lactate 
measurements were consistently lower than 
plasma lactate,	 probably due to the dilutional 
effect of the erythrocytes, which are poorer in 
lactate than plasma (Radostits et al., 2007). 	
Despite de differences in values, both plasma 
measurements behave in a similar manner 
along the time points.  
The increase in lactate concentration after the 
administration of the LRS bolus (T1) can be 
explained by the ability of the analyzers to 
detect this solution’s lactate. Although it was 
not tested on the iStat®, we tested the Vet 
One® Lactated Ringer’s Solution on the Nova 
Biomedical Lactate Plus® which detected 5,2 
mmol/L of lactate present in this solution. This 
means that for each 2L bolus of LRS the 
horses received 10,4 mmol  of lactate 
detectable by our analyzer. If we consider the 
plasma volume to be 0.052 to 0.063 L/kg in 
healthy adult horses (Fielding, 2015a), for a 
450 Kg this would result in an increase of 0,37 
to 0,44 mmol/L in plasma lactate. It is important to mention that this calculation does not take in 
account several variables such as the metabolization rate of such lactate and the volemia status 
of the horse at that time.  
Nonetheless, the animals from the HSS not only experienced a considerable drop in lactate at 
T1 as these values remained lower than those of the LRS group at T2, regardless of the initial 
group mean being higher than the LRS group’s. 
Graphic 11: Plasma lactate mean ± SE for the HSS and 
LRS groups at T0, T1 and T2. 
Graphic 12: Whole blood lactate mean ± SE for the HSS 
and LRS groups at T0, T1 and T2. 
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Normal plasma lactate values for adult horses are generally considered to be less than 1,5 
mmol/L (Nappert & Johnson, 2001; Fielding & Magdesian, 2005;) or 2,0 mmol/L (Magdesian, 
2004), and increases in blood lactate concentrations have been strongly related to worse 
prognosis in several species as explained on chapter 1.9.  
Even though the plasma lactate levels of the horses enrolled in our study were not alarmingly 
high, the administration of hypertonic saline solution was likely to improve microhemodynamics 
and organ perfusion. This effect justifies how lactate concentrations for the HSS group kept 
diminishing, whereas the other blood variables increased from T1 to T2, after the effects of the 
hypertonic solution ended. The continuous decrease in lactate, can’t be attributed solely to the 
dilution of the bloods constituents after plasma expansion but also to the decline in lactate 
production by the cells upon circulation improvements.  
2.4.8. Blood pH 
pH mean for both groups at T0, T1 and T2 are presented in Graphic 13. 
Although blood pH was not extensively reviewed in this dissertation, there is the eventual 
concern about causing an iatrogenic acidosis by the administration of hypertonic saline due to its 
low pH and absence of a buffer component.  
Mean pH at T0 and at T1 for the HSS group was of 7,33 ± 0,06 and 7,30 ± 0,05, respectively, 
which represents a decrease of 0,03 units in 
mean pH between T0 and T1 for the HSS group. 
 The biggest decrease in pH for the HSS group 
was of 0,045 units which fits Constable’s (2003) 
statement that the decrease in pH caused by 
HSS in large animals is less than 0.08.  
At T2 the mean pH for the HSS group was similar 
to T0, indicating that, besides being of little value, 
the drop in pH is also short lasting in animals 
receiving hypertonic saline solution. 
  
Graphic 13: pH mean ± SE for the HSS and LRS 
groups at T0, T1 and T2. 
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2.5. Study limitations and future considerations 
This was a preliminary study and it is our intention to gather data from a larger sample in order 
to achieve a greater statistical power. 
The biggest limitation of our study was the sample size. However, we were limited by the 
enrollment criteria created in the beginning. Although more than eight horses fit the enrollment 
criteria, some owners declined IV fluid therapy due to budget limitations.  
The heterogeneity of the group of horses used was another limitation for our study. Among this 
sample there were horses of different ages, weights, diagnosis and breeds. It was also hard to 
define the time that passed between the onset of colic and the hospital admission for these 
horses. Nonetheless, we hope that increasing our sample will balance both groups and reflect a 
larger population. 
All horses had at least one variable that could be considered as being within normal limits, which 
could lead to the debate about the need for some animals to receive IV fluids. However, the goal 
of this study was to reflect a practical approach to colic treatment and it was decided that it 
would be up to the practitioner in charge of each case to decide about the horse’s need for VI 
fluid therapy. A larger sample is expected to reflect the hemodynamic status of horses with 
medical colics with greater accuracy. 
The administration of a bolus of LRS proved to interfere with the real plasma lactate 
concentrations, and probably the BUN concentrations as well, of the LRS group. This should be 
taken into account and the replacement of the LRS by a lactate free isotonic polyionic solution 
should be considered before proceeding with more data collection. 
Due to the length limitations of this dissertation more variables were collected than the ones 
presented and discussed here. However it is our intention to present these variables in the 
future and after the gathering of a larger, more representative sample. 
Even though these were not the goals of this work, it could be interesting to further investigate 
the amount of fluids each horse received before being released from the hospital, the effects of 
HSS in specific types of colic, the reason for the increases in BUN after the administration of 










The major limitation of this work was the small sample size, which didn’t allow us to calculate the 
existence of significant differences between horses treated with hypertonic saline solution and 
the control group. However, the pattern observed for most variables of the HSS is clear.  
Central venous pressure and arterial blood pressures increased visibly after treatment with HSS, 
dropping after the effect of this solution had passed. However, at the end of 90 minutes and after 
the administration of 10 litters of isotonic crystalloids, CVP and arterial blood pressures were still 
higher than baseline. 
The opposite happened for blood parameters known to be related with worse prognosis in 
equine colic, such as PCV, TP and creatinine, that decreased after treatment with HSS and 
increased slightly after the effects of the HSS worn off and the 10 litter bolus of isotonic fluids 
was administered.  
Plasma lactate decreased continuously after the administration of the HSS bolus and of the 10L 
isotonic fluid, indicating us that, even after the effects of the hypertonic solution had passed, 
organ perfusion was improved and lactate production by the body’s cells had stopped. 
The effects of HSS like the increase in plasma volume and cardiac function, the reestablishment 
of microhemodynamics and improvement of organ perfusion, and the reduction of tissue lesions 
due to ischemia or inflammatory processes are believed to exert protective effects even in 
horses with subclinical hypovolemia.  
A single bolus of HSS seems to promote a bigger increase in blood flow to organs like heart, 
kidney, liver and intestines, which allows us to quickly secure vital functions while administering 
larger volumes of isotonic crystalloids. 
Despite the small size of our sample, it is possible to affirm that some of the effects obtained at 
T1 for the HSS group were only achieved at T2 for the LRS group. 
Although the dose of HSS administered to some horses was superior to the standard 4 ml/Kg of 
body weight, no deleterious effects were noticed with doses up to 4,6 ml/Kg.  
The observed results support our hypothesis that horses with medical colics also benefit from 
treatment with HSS and encourage us to proceed with data collection in order to obtain a larger 
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Appendix 1 – Results table 
 
HSS vs LRS groups values according to time point 
T0 T1 T2 
 x̅ SD SE CI x̅ SD SE CI x̅ SD SE CI 
PCV 
 (%) 
HSS 45,00 8,72 4,36 13,87 31,5 5,26 2,63 8,37 34,0 5,42 2,71 8,62 
LRS 45,25 4,57 2,29 7,28 40,75 4,57 2,29 7,28 38,50 5,00 2,50 7,90 
ALB 
(g/dL) 
HSS 3,10 0,29 0,15 0,47 2,15 0,13 0,06 0,21 2,45 0,13 0,06 0,21 
LRS 3,15 0,13 0,06 0,21 3,02 0,10 0,05 0,15 2,68 0,13 0,06 0,20 
TS 
(g/dL) 
HSS 7,75 0,66 0,33 1,05 5,85 0,82 0,41 1,31 6,25 0,82 0,41 1,31 
LRS 7,40 0,52 0,26 0,82 6,65 0,53 0,26 0,84 6,00 0,59 0,29 0,94 
TP  
(g/dL) 
HSS 7,53 0,82 0,41 1,30 5,75 0,79 0,40 1,26 6,23 0,91 0,46 1,445 
LRS 7,00 0,50 0,25 0,80 6,63 0,67 0,33 1,06 5,98 0,63 0,32 1,01 
BUN 
(mg/dL) 
HSS 19.95 7,35 3,67 11,69 19,65 7,50 3,75 11,94 18,60 6,98 3,48 11,09 
LRS 19,85 3,67 1,84 5,84 21,25 4,89 2,45 7,79 20,70 4,21 2,10 6,69 
CRE 
(md/dL) 
HSS 2,02 0,33 0,17 0,53 1,7 0,23 0,12 0,37 1,73 0,26 0,13 0,42 
LRS 1,45 0,52 0,26 0,83 1,43 0,50 0,25 0,79 1,33 0,36 1,18 0,57 
CVP 
(cmH2O) 
HSS 10,5 7,72 3,86 12,29 14,75 5,91 2,95 9,40 12,75 3,30 1,65 5,26 
LRS 9,50 9,75 4,87 15,51 11,00 10,03 5,02 15,97 13,75 8,66 4,33 13,77 
MAP 
(mmHg) 
HSS 71,0 17,98 8,99 28,61 99,25 16,54 8,27 26,32 90,75 23,88 11,94 38,0 
LRS 91,00 12,36 6,18 19,66 88,75 4,57 2,29 7,28 96,25 15,88 7,94 25,27 
SYS 
(mmHg) 
HSS 91,75 20,89 10,44 33,24 127,50 14,15 7,08 22,52 119,0 28,5 14,25 45,34 
LRS 115,00 13,09 6,54 20,83 112,25 7,27 3,64 11,58 134,0 23,34 11,67 37,14 
DIS 
(mmHg) 
HSS 63,0 14,90 7,45 23,71 84,0 18,83 9,42 29,97 73,75 19,09 9,54 30,37 
LRS 79,25 14,93 7,47 23,76 76,25 5,91 2,95 9,40 80,50 13,18 6,59 20,97 
PCV: packed cell volume; ALB: albumin; TS: total solids; TP: total protein; BUN: blood urea nitrogen; CRE: creatinine; CVP: central venous pressure; MAP: mean arterial pressure; SYS: systolic blood 








HSS vs LRS groups values according to time point (cont.) 
T0 T1 T2 
x̅ SD SE CI	 x̅	 SD	 SE	 CI	 x̅	 SD	 SE	 CI	
PLac 
(mmol/L) 
HSS 1,70 0,97 0,48 1,54 1,05 0,47 0,24 0,75 0,85 0,13 0,06 0,21 
LRS 1,18 0,30 0,15 0,48 1,85 0,58 0,29 0,92 1,03 0,44 0,22 0,70 
BLac 
(mmol/L) 
HSS 1,09 0,47 0,24 0,75 0,77 0,32 0,16 0,50 0,55 0,13 0,07 0,21 
LRS 0,92 0,31 0,15 0,49 1,28 0,42 0,21 0,67 0,74 0,37 0,19 0,59 
pH 
HSS 7,33 0,06 0,03 0,10 7,30 0,05 0,03 0,08 7,32 0,06 0,03 0,1 
LRS 7,39 0,05 0,02 0,08 7,40 0,04 0,02 0,06 7,41 0,05 0,03 0,08 




Appendix 2 – Data sheet 
																																						Hypertonic	Saline	Solution	
																																																																																			A										B	
	
	
Horse:	
Age:	
Date:	
Gender:	
Diagnosis:	
Breed:	
	
Weight	 0,	1	&	90	min:	Chemistry	+	Electrolytes	+	CG4	
	
0	&	24h:	WBC	
Kg	0:	
Kg	24h:	
	 	
Physical	exam		
HR	0:	 JF	0:	 CRT	0:	
HR	1:	 JF	1:	 CRT	1:	
HR	90:	 JF	90:	 CRT	90:	
	 	 	
Blood	pressure	(3	measurements	each)	 	
NIBP	0:		
	
	
MAP	0:	 CVP	0:	
NIBP	1:	
	
	
MAP	1:	 CVP	1:	
NIBP	90:	
	
	
MAP	90:	 CVP	90:	
	 	 	
Lab	work	
LAC	0:	 TS	0:	 PCV	0:	
LAC	1:	 TS	1:	 PCV	1:	
LAC	90:	 TS	90:	 PCV	90:	
	 	 	
Notes:	
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